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Abstract
Hospital patients recovering from major cardiac surgery are at high risk of postoperative
atrial fibrillation (POAF), an arrhythmia which can be life-threatening. With the develop-
ment of a tool to predict POAF early enough, the development of the arrhythmia could
be potentially prevented using prophylactic treatments, thus reducing risks and hospital
costs. To date, no reliable method suitable for autonomous clinical integration has been
proposed yet.
This thesis presents a study on the prediction of POAF using the electrocardiogram. A
novel P-wave quality assessment tool to automatically identify high-quality P-waves was
designed, and its clinical utility was assessed. Prediction of paroxysmal atrial fibrillation
(AF) was performed by implementing and improving a selection of previously proposed
methods. This allowed to perform a systematic comparison of those methods, and to test
if their combination improved prediction of AF. Finally, prediction of POAF was tested
in a clinically relevant scenario. This included studying the 48 hours preceding POAF,
and automatically excluding noise-corrupted P-waves using the quality assessment tool.
The P-wave quality assessment tool identified high-quality P-waves with high sensitiv-
ity (0.93) and good specificity (0.84). In addition, this tool improved the ability to predict
AF, since it improved the precision of P-wave measurements. The best predictors of AF
and POAF were measurements of the variability in P-wave time- and morphological fea-
tures. Paroxysmal AF could be predicted with high specificity (0.93) and good sensitivity
(0.82) when several predictors were combined. Furthermore, POAF could be predicted
48 hours before its onset with good sensitivity (0.74) and specificity (0.70). This leaves
time for prophylactic treatments to be administered and possibly prevent POAF. Despite
being promising, further work is required for these techniques to be useful in the clinical
setting.
Keywords: Postoperative atrial fibrillation, electrocardiogram, P-wave, prediction.
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Resumo
Pacientes a recuperar de cirurgia cardíaca estão em alto risco de desenvolver fibrilação
auricular pós-operativa (FAPO), uma arritmia potencialmente fatal. O desenvolvimento
de uma ferramenta para prever a FAPO permitiria evitar a arritmia através de tratamentos
profiláticos, reduzindo assim os riscos e custos hospitalares associados. Até ao momento
não existe nenhuma técnica fidedigna capaz de integração autónoma no meio clínico.
Esta tese apresenta um estudo sobre a previsão da FAPO através do eletrocardiograma.
Foi criada uma ferramenta inovadora que permite a identificação automática de ondas-P
de alta qualidade, e a sua utilidade foi testada no contexto clínico. A previsão da fibrilação
auricular (FA) paroxística foi realizada através da implementação e melhoria de uma
seleção de métodos propostos na literatura. Isto permitiu a realização de uma comparação
sistemática entre esses métodos, e testar se a sua combinação melhora a previsão da
FA. Finalmente, a previsão da FAPO foi realizada num cenário clinicamente relevante:
estudando as 48 horas anteriores ao começo da arritmia, e excluindo automaticamente
ondas-P corrompidas por artefactos através da ferramenta de avaliação de qualidade.
A ferramenta de avaliação de qualidade das ondas-P identificou ondas-P de alta quali-
dade com alta sensibilidade (0,93) e boa especificidade (0,84). Além disso, esta ferramenta
melhorou a capacidade de prever a FA, através do aumento da precisão das medições reti-
radas das ondas-P. Os melhores previsores da AF e FAPO foram medidas de variabilidade
dos intervalos e morfologia da onda-P. A FA paroxística foi prevista com alta especifici-
dade (0,93) e boa sensibilidade (0,82) através da combinação de vários métodos. A FAPO
foi prevista com 48 horas de antecedência com boa sensibilidade (0,74) e especificidade
(0,70). Esta antecedência permite que os tratamentos profiláticos sejam administrados
e possivelmente evitem a FAPO. Apesar dos resultados promissores, trabalho futuro é
necessário para que estas técnicas sejam úteis na prática clínica.
Palavras-chave: Fibrilação auricular pós-operativa, electrocardiograma, onda P, previsão.
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This thesis includes work that will be reported in different publications.
Currently, the work presented in Chapter 4 will be presented in the 5th International
Electronic Conference on Sensors and Applications (ECSA-5). This will be published as a
conference paper, entitled "Automated P-wave quality assessment for wearable sensors".
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Introduction
Atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical practice, and
a well-recognized complication of cardiac surgery [1]. Patients recovering from major
cardiac surgery are at high-risk of developing postoperative AF (POAF), with an incidence
of 11% - 62%, depending on the type of surgery [2–7]. Importantly, the frequency of this
arrhythmia appears to be increasing, most likely due to the increasing age of patients
undergoing cardiac surgery [8].
Even though AF is self-limiting in nature, this arrhythmia is associated with increased
risk of stroke and hemodynamic compromise, mortality, increased length of hospital stay,
and health care costs [9–11]. In the long term, patients who develop POAF have a twofold
increase in cardiovascular mortality [12], and a substantial increase in the risk of future
AF and ischemic stroke, compared to patients who remain in sinus rhythm after surgery
[13–15].
Prophylactic treatment has been shown to be effective in the prevention of POAF [16–
20]. However, it is not routinely used because indiscriminate use of prophylactic agents
does not outweigh the risks of side effects [21, 22] and has added costs [22]. Therefore, if a
tool could be developed to predict the onset of POAF early enough, then the development
of the arrhythmia could potentially be prevented using prophylactic treatments, thus
reducing risks and hospital costs.
This issue has been approached both pre- and postoperatively, achieving encouraging
yet insufficient results. The P-wave from the electrocardiogram (ECG) has been widely
studied since it reflects atrial depolarization. Preoperative risk stratification has used AF
risk factors, with or without ECG measurements, to identify patients at risk of develop-
ing AF [23]. Even though these studies have identified important factors that predispose
individuals to the arrhythmia, their clinical application is limited by their moderate per-
formance. More recently, long-term continuous monitoring has led to the identification
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of subtle P-wave alterations that were found to predict AF at least 2 hours before its onset
with high accuracy [24–27].
Although considerable progress has been achieved in the prediction of AF, no reliable
method suitable for autonomous clinical integration has been proposed yet. Several ad-
ditional steps are required to implement such systems in clinical practice. The first step
concerns the improvement of predictive methods and evaluation in clinically relevant
scenarios. This includes the prediction of POAF sufficiently long before its onset when
prophylactic treatment is beneficial and the inclusion of heart rhythms other than sinus
rhythm, which are commonly found in the postoperative setting. Secondly, such predic-
tion techniques need to be adapted for unsupervised use during continuous monitoring,
where ECG data is susceptible to artefacts that lead to inaccurate measurements.
1.1 Thesis Goals
This thesis aimed to address several of the steps required before techniques to predict
POAF can be implemented in the clinical setting. The hypothesis of this project is that:
ECG signals can be analysed to predict the onset of POAF with sufficient warning time to
allow prophylactic treatment to be administered.
Several goals were identified in order to achieve the overall aim as follows:
• Design a P-wave quality assessment tool, and assess its performance and clinical
utility. This tool will automatically assess P-wave quality. Performance assessment
will include the ability to distinguish between high and low quality data. The
clinical utility of the tool will be assessed by testing if the developed tool improves
the precision of several P-wave feature measurements and prediction of AF.
• To identify, implement and improve previously proposed methods for predict-
ing AF using the ECG signal, and assess their performance using a database
containing records from healthy subjects and patients before the onset of AF.
Performance assessment will include the ability to distinguish between controls
and subjects who subsequently develop AF, and to predict the imminent onset of
the arrhythmia in subjects who develop AF.
• Assess the performance of the previously implemented methods to predict POAF
on a real world clinical database. Prediction of POAF will be performed in a clini-
cally relevant scenario: 48 hours before the arrhythmia and without supervision.
The novelties of this study are that it is the first to predict POAF during a clinically
realistic scenario, and that it is the first investigating the 48 hours prior to the onset of
the arrhythmia. Furthermore, this study is the first to perform a systematic comparison
of previously proposed methods, and test if they can be used in combination to improve
2
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prediction of AF. Finally, a novel P-wave quality assessment tool is presented, which
allows the AF prediction to be conducted without supervision.
1.2 Thesis Outline
The thesis is structured as follows. Chapter 2 presents the clinical background, including
the cardiovascular system, the ECG signal, and an overview of both AF and POAF. In
Chapter 3 the state of the art on the prediction of AF is presented, including preoperative
AF risk stratification and postoperative prediction of POAF. In chapter 4 a novel P-wave
quality assessment tool is presented, and its performance and clinical utility are assessed.
Chapter 5 presents a study on the ability of several proposed methods for predicting
paroxysmal AF. Chapter 6 presents a study of the performance of these methods when
predicting POAF in a clinically relevant scenario. Finally, Chapter 7 presents a summary
of the achievements of this thesis and directions for future work.
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Clinical Background
In this chapter the clinical background to this thesis is presented. Firstly, the cardio-
vascular system is presented, including a physiological monitoring technique: the elec-
trocardiogram (ECG). This is followed by an overview of atrial fibrillation (AF) and
postoperative atrial fibrillation (POAF), including their epidemiology, mechanisms, risk
factors and the current treatment methodologies.
2.1 The cardiovascular system
The heart consists of four muscular chambers. The left and right ventricles are the main
pumping chambers, whilst the less muscular left and right atria deliver blood to their
respective ventricles. Four major valves in the healthy heart direct blood flow in a for-
ward direction and prevent backward leakage. The atrioventricular valves (tricuspid and
mitral) separate the atria and ventricles, whereas the semilunar valves (pulmonary and
aortic) separate the ventricles from the great arteries [28]. From a functional point of view,
the deoxygenated blood is delivered to the heart through the inferior and superior venae
cavae, and enters the right atrium. Flow continues through the tricuspid valve into the
right ventricle. Contraction of the right ventricle pumps the blood across the pulmonary
valve to the pulmonary artery and lungs, where carbon dioxide is released and oxygen
is absorbed. The oxygen-rich arterial blood returns to the heart through the pulmonary
veins to the left atrium and then passes through the mitral valve into the left ventricle.
Contraction of the left ventricle propels the arterial blood through the aortic valve into
the aorta, from where it is distributed to all other tissues across the body [28].
Cardiac contraction relies on the organized flow of electrical impulses through the
heart’s impulse-conducting system. The normal heartbeat begins at the sinoatrial (SA)
node, located at the junction of the right atrium and the superior vena cava (Figure
5
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2.1). The wave of depolarization spreads rapidly through the right and left atria and
then reaches the atrioventricular (AV) node, where it encounters an expected delay (of
approximately 0.1 seconds). This pause in conduction is beneficial in the sense that allows
the atria time to contract and fully empty their contents and serves as a “gatekeeper” of
conduction from atria to ventricles, limiting the rate of ventricular stimulation during
atrial arrhythmias [28]. After traversing the AV node, the impulse then travels rapidly
through the bundle of His and into the right and left bundle branches. Those, in turn,
divide into the Purkinje fibres, which radiate toward the myocardial fibres, stimulating
them to depolarize and contract, pumping the blood through the respective valves [28].
2.1.1 The electrocardiogram
The aforementioned electrical activity of the heart results in small currents within the
body and potential differences on the surface of the skin, which can be measured using
skin electrodes. Each healthy heartbeat is represented on the ECG by three major deflec-
tions that record the sequence of electrical propagation. The P-wave represents the atrial
depolarization, and is followed by a period of baseline resulting from the conduction de-
lay at the AV node (PR interval). The second and more pronounced deflection on the ECG
is the QRS complex, which represents the ventricular depolarization. After a brief delay
during baseline, the T-wave surges representing ventricular repolarization (Figure 2.1).
Occasionally, an additional small deflection named the U-wave follows, representing late
phases of ventricular repolarization [28].
ECG P
QRS complex:
ventricular
depolarization
T
 
RA
LA
LV
RV
SA node
SA node
Purkinje
fibres
AV node
P-wave: atrial
depolarization
T-wave: ventricular
repolarization
Q
R
S
Figure 2.1: Representation of the electrical activity of the heart during sinus rhythm (top),
and corresponding electrocardiogram (ECG; bottom). Adapted from Lip et al. [11].
2.2 Atrial Fibrillation
AF is a supraventricular arrhythmia with an atrial discharge rate so fast (350 to 600
discharges per minute) that distinct P waves are not discernible on the ECG [28], resulting
in low-amplitude baseline oscillations [29]. As many of the atrial impulses encounter
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refractory tissue at the AV node, allowing only some of the depolarization to be conducted
to the ventricles in a very irregular fashion, the result is an “irregularly irregular” rhythm
(Figure 2.2). The average ventricular rate in untreated AF is approximately 140 to 160
beats per minute (bpm) [28].
This disorder is the most common cardiac rhythm disorder, with an increasing global
prevalence and incidence [1]. The most serious complications of AF include stroke, sys-
temic thromboembolism, heart failure, and dementia, contributing to increased mortality
and morbidity, and entailing high costs for families and society. The current economic
burden of AF in Europe is substantial, with widespread implications for the planning of
national health care systems [30], as the rate of hospitalization and treatment costs are
increasing in epidemic proportions [31].
2.2.1 Epidemiology
AF is the most common arrhythmia found in clinical practice, affecting approximately
4.5 million in the European Union and 2.2 million in North America. Furthermore, AF is
responsible for nearly 33% of arrhythmia-related hospitalizations [28]. There are almost
five million new cases of AF every year, with the number of affected individuals expected
to increase continuously in an exponential fashion [11, 32, 33]. The cause of this global
increase might be due to an ageing population, since age is the strongest risk factor for
developing AF. Furthermore, improvements in how conditions associated with AF are
managed might also contribute to the increased AF rates, as survival of these conditions
can be associated with cardiac damage, which also predisposes to AF [11].
AF is linked to numerous serious complications: a four- to five-fold increased risk
of stroke [11, 34, 35], a three-fold increased risk of heart failure, and a nearly two-fold
increased risk of all-cause mortality [36]. Strokes related to AF are associated with greater
mortality, disability, with longer hospital stays, and lower rates of discharge to a patient’s
own home, compared with strokes that are not associated with AF [37]. Patients with
AF generally experience increased morbidity and more admissions to hospital than those
who do not have the arrhythmia. Increasing evidence also suggests an association between
AF and an increased risk of ‘premature’ dementia [11].
2.2.2 Mechanisms
The central feature of AF is very rapid and irregular atrial activity. This generally requires
a trigger to be initiated, which is typically a focal spontaneous firing. These triggers most
commonly arise as rapid firing foci in sleeves of atrial muscle that extend into the pul-
monary veins (PV), although it can also emerge from non-PV foci [11]. In paroxysmal AF
(i.e., sudden, unpredictable episodes), AF is often initiated by these rapid discharges from
the PV, reflected in premature atrial complexes [38–41]. The mechanism maintaining the
arrhythmia often arises in what is commonly referred to as vulnerable substrate. This
substrate might be associated with the several risk factors, such as genetic predisposition,
7
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(a) Sinus rhythm                                                                                 (b) Atrial brillation
ECG
Normal beat
Atrial brillation onset
Figure 2.2: Electrical conduction during sinus rhythm and atrial fibrillation. Schematic
diagrams of cardiac mechanisms (top of each panel) and electrocardiograms (ECGs; bot-
tom of each panel) in (a) normal sinus rhythm and (b) atrial fibrillation. Adapted from
Lip et al. [11].
cardiac remodelling caused by heart disease, and/or altered regulation by neurohormonal
factors such as autonomic imbalance and overactive thyroid function.
Each of the following three principal mechanisms can maintain the chaotic rhythm
that comprises AF [11] (Figure 2.3):
1. One or more rapidly firing atrial ectopic foci may be present, with irregular conduc-
tion towards the rest of the atria, producing irregular fibrillary-like activity.
2. One or a small number of primary re-entry circuits (or rotors) may produce rapid
local activation, with fibrillary conduction causing AF.
3. Multiple functional re-entry waves with irregular patterns and no consistent acti-
vation pattern, maintaining the disordered AF rhythm.
In fact, slowed conduction velocity together with decreased cell refractory periods are
believed to provoke and maintain AF, as such abnormalities result in a non-uniform and
anisotropic atrial conduction which plays a major role in the initiation of re-entry.
The electromechanical consequences of AF have serious clinical implications. The
absence of effective atrial contraction increases the risk of blood coagulation and throm-
bosis. Furthermore, the rapid and irregular ventricular rate generated by the arrhythmia
reduces the efficiency of ventricular contraction, affecting hemodynamics and, ultimately,
causing heart failure [11, 42].
2.2.3 Risk factors
Most risk factors are consistently associated with an increased risk of developing AF
across all ethnic groups [11], even though ethnicity itself is reported to affect the inci-
dence of the arrhythmia [43, 44]. AF is more common in elderly male individuals with
cardiovascular abnormalities, such as hypertension, ischemic heart disease, or forms of
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structural heart disease. Obesity and obstructive sleep apnea, although related, have been
found to independently increase the risk for AF. The most common temporary causes are
excessive alcohol consumption, open heart or thoracic surgery (POAF), myocardial infarc-
tion, pericarditis, myocarditis, and pulmonary embolism. The most common correctable
cause if hyperthyroidism [28].
(a)   Rapidly discharging focus (b)   Primary rotor(s) (c)   Multiple functional re-entry
waves/rotors
Pulmonary
veinsSA node
Purkinje
AV node
Figure 2.3: Mechanisms responsible for atrial fibrillation maintenance. Ectopic electrical
impulses that propagate throughout the atrial myocardium in a disordered way can be
maintained through a variety of mechanisms: (a) a rapidly discharging atrial focus, (b)
primary re-entrant rotor(s), (c) multiple functional re-entry circuits. AF, atrial fibrillation;
AV, atrioventricular; LA, left atrium; LV, left ventricle; PV, pulmonary vein; RA, right
atrium; SA, sinoatrial. Adapted from Lip et al [11].
2.3 Postoperative Atrial Fibrillation
POAF is the most frequent complication of cardiac surgery [9], with a prevalence depen-
dent on the type and technique of surgery, patient characteristics, method of arrhythmia
surveillance, and definition of the arrhythmia [20]. Importantly, the incidence of POAF
is increasing, most likely due to the increasing number of elderly subjected to cardiac
surgery. Similarly to other types of AF, it affects patient well-being, by increasing the risks
of stroke, hemodynamic compromise, and mortality [13, 14]. Furthermore, it increases
the hospital length of stay, and incurs additional treatment costs [9].
9
CHAPTER 2. CLINICAL BACKGROUND
2.3.1 Epidemiology
The incidence of POAF ranges from 11% to 62%, with the highest rate after combined
coronary artery bypass grafting (CABG) and valve surgery [7, 45]. POAF may also occur in
up to 40% in patients undergoing CABG surgery [4–6], 35% to 40% after valvular surgery
[4, 5, 46], and 11% to 24% after cardiac transplantation [4, 5]. Initial onset of AF occurs
most commonly on postoperative days two or three [6], and the majority of episodes
occur within the first six days following cardiac surgery [10]. The incidence in patients
undergoing non-cardiothoracic surgery varies between 0.3% and 30%, depending greatly
on the specific surgical procedure [47–50].
POAF is associated with increased incidence of other postoperative complications,
stroke being the most recognized, with a threefold risk increase [4, 51]. There is evi-
dence of association between POAF and myocardial infarction, congestive heart failure,
ventricular arrhythmias, renal insufficiency, hypotension, pulmonary edema, pneumonia,
mediastinitis or deep sternal wound infection, sepsis, and harvest site infection. (It is
important to note that these associations do not necessarily indicate a causal relationship
between POAF and the mentioned complications, as it may just be an epiphenomenon [8]).
Patients who develop POAF are also associated with the need for a permanent pacemaker,
inotropic medications, prolonged ventilation, readmission to the ICU, and consequent
increased hospital length of stay [51]. The impact of POAF on hospital resources is sig-
nificant, with an extra cost of care of approximately $10,000 (8,700€) per patient in the
United States [3]. In the long term, patients with an episode of POAF have a twofold
increase in cardiovascular mortality [12], and a substantial increase in the risk of future
AF and ischemic stroke, compared to patients who remain in sinus rhythm after surgery
[13–15].
2.3.2 Mechanisms
The electrophysiological mechanisms underlying AF after cardiac surgery are not fully
understood. However, it is believed that patients who develop POAF may already have
preexisting atrial substrate for this arrhythmia before surgery [8], such as atrial fibrosis
or dilation, with surgery being the trigger for AF. In patients undergoing cardiothoracic
surgery this trigger can be related to the intraoperative trauma, manipulation of the
heart, local inflammation (with or without pericarditis), elevated atrial pressure due
to postoperative ventricular stunning, and the rapid return of atrial temperature after
cardioplegia [45, 52]. In all-type surgical patients, AF can also be related to specific
factors, such as direct cardiac stimulation from the perioperative use of catecholamines
or reflex sympathetic activity from volume loss, anemia, fever, hypo- or hyperglycemia,
and electrolyte disturbances [45]. There is also evidence that inflammation, both systemic
and local, may play a role in the pathogenesis of POAF [52]. These surgical factors may
therefore trigger POAF in susceptible patients through dispersion of atrial refractoriness
[53], non-uniform atrial conduction [54], or increased premature atrial complexes [39]
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(Figure 2.4).
2.3.3 Risk factors
Documented risk factors for the development of POAF can be divided into preoperative,
perioperative and postoperative. In addition to common AF risk factors such as increased
age and cardiovascular disease, other preoperative factors such as prior history of AF and
hypothyroidism have been associated with the postoperative arrhythmia. Intraoperative
variables include type of surgery, aortic cross-clamp time, the early return of atrial elec-
trical activity after cardioplegia, atrial ischemia, systemic and pericardial inflammation,
systemic hypothermia, and electrolytic imbalances, such as hypokalemia and hypomag-
nesemia. Postoperative conditions associated with POAF include respiratory compromise,
which can be due to postoperative pneumonia, and hypotension.
Preopera�ve factors:
- Advanced age
- Hypertension
- Diabetes
- Obesity
- Prior history of AF
- Le� atrial enlargement
- Diastolic dysfunction
- Le� ventricular hypertrophy
- Gene�c predisposi�on
Intraopera�ve factors:
- Surgery type
- Aor�c cross-clamp �me
- Systemic hypothermia
- Acute volume changes
- Atrial ischemia
Postopera�ve factors:
- Respiratory
compromise
- Volume overload
- Hypotension
- Red cell transfusion
Triggers:
- Atrial premature contrac�ons
- Imbalance of autonomic
nervous system
- Electrolyte imbalance
(hypomagnesemia,
hypokalaemia)
- Inflamma�on 
- Oxida�ve stress
Atrial structural substrate
Atrial electrophysiological substrate
Postopera�ve
Atrial Fibrilla�on
Dispersion of atrial refreactoriness and non-uniform atrial conduction
Figure 2.4: Pathogenesis of postoperative atrial fibrillation. It is believed that patients
who develop POAF may already have preexisting atrial substrate that, together with
intra- and post-operative factors, may trigger POAF through dispersion of atrial refrac-
toriness, non-uniform atrial conduction, or increased premature complexes. Adapted
from Echahidi et al [9].
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2.3.4 Prevention
Many studies have evaluated the effectiveness of pharmacologic and non-pharmacologic
interventions to prevent the onset of POAF, and therefore decrease its growing incidence.
Current practice is based on the 2016 European Society of Cardiology (ESC) guidelines
[55], and is presented bellow.
Beta-blockers. Beta-Adrenergic blockade helps reduce the effect of increased sympa-
thetic activation, which is believed to be a significant contributor to the development of
AF in the postoperative period, and to be present in patients undergoing cardiac surgery
[9]. The preoperative initiation of beta-blockers has been demonstrated to be more effec-
tive than postoperative initiation. These drugs have the additional benefit of controlling
the ventricular rate in the event of AF. Due to the extensive evidence of benefits from
beta-blockers, the 2016 ESC guidelines presented a class I recommendation to perioper-
ative beta-blocker therapy in patients subjected to cardiac surgery [55]. Although it is
cost-effective for the reduction of AF, no significant decreases in hospital length of stay
[17, 56] and overall cost of care have been observed [56]. The anti-arrhythmic effect of
beta-blockers peaks immediately when administered intravenously (IV), and after 1 to
1.5 hours when administered orally [57]. Adverse effects include bradycardia, fatigue,
bronchospasm, hypotension, and aggravation of heart failure [58, 59].
Amiodarone. Amiodarone has alpha- and beta-adrenergic blocking properties that
might attenuate the elevated sympathetic stimulation seen in patients undergoing cardiac
surgery [9, 60]. This anti-arrhythmic drug was found to reduce the incidence of POAF
compared to beta-blocker therapy in several meta-analyses, also reducing hospital length
of stay [55]. Perioperative amiodarone should be considered as prophylactic therapy to
prevent POAF (class IIa in 2016 ESC guidelines), particularly so in high-risk patients
[61]. The anti-arrhythmic effect of amiodarone peaks between 1 minute and 1.5 hours
after IV administration [62]. When administered orally, the drug concentration peaks
after 3 to 7 hours [63, 64], but the anti-arrhythmic effects only start after 2/3 days to
1/3 weeks [62, 65] (the oral absorption rate is slow and variable because amiodarone is
highly lipophylic [58]). Adverse effects include symptomatic bradycardia and heart block
in patients with pre-existing sinus or AV node disease, dose-related pulmonary toxicity,
and hypo- or hyperthyroidism [59].
Although not present in the 2016 ESC guidelines, other therapies have also been
studied, showing a decrease in POAF. Pharmacologic therapies include magnesium,
colchicine, and corticosteroids [55]. A non-pharmacologic approach includes prophy-
lactic atrial pacing, which acts through the suppression of atrial premature complexes
and dispersion of atrial refractoriness, which are known to facilitate the onset of POAF
[41, 45]. Despite suggestions of its prophylactic effects, biatrial pacing has not gained
widespread use [55].
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2.3.5 Treatment
Although POAF can be transient and self-limiting, treatment is indicated for patients who
remain symptomatic, are hemodynamically unstable, and develop cardiac ischemia or
heart failure [9]. Conventional treatment strategies include restoration/maintenance of
sinus rhythm, control of ventricular rate response, and prevention of thromboembolic
events. The treatment of POAF is manly based on studies of patients undergoing cardiac
surgery, with much lower evidence on non-cardiac surgery [55].
Rate control. The postoperative period is characterized by increased adrenergic stress,
which might difficult ventricular rate control in patients with POAF. Short-acting beta-
blockers are the most widely used therapy, except for patients with contraindications to
such agents. For those, other AV nodal blocking agents such as the nondihydropyridine
calcium-channel blocker, can be used. Amiodarone is also effective in controlling heart
rate, being further associated with improved hemodynamic status [9].
Rhythm control. In symptomatic patients or in cases of difficult control of ventric-
ular response, cardioversion (i.e., conversion to sinus rhythm) is preferred. Chemical
cardioversion with agents such as amiodarone, procainamide, ibutilide, and sotalol might
be effective. Electrical cardioversion should be urgently performed when POAF results
in hemodynamic instability, acute heart failure, or myocardial ischemia. This shock-
procedure is electively used to immediately restore sinus rhythm after the first onset of
AF when a pharmacologic attempt has failed [9]. In postsurgical patients, electrical car-
dioversion may be done either externally (transthoracic) or internally, using low-energy
transvenous electrodes or epicardial wires placed during surgery. As atrial stunning per-
sists after cardioversion, anticoagulation is recommended for the three to four weeks
after conversion procedure. Thromboembolism is a major concern of cardioversion, ei-
ther pharmacologically or electrically, particularly when POAF has been present for more
than 48h [9].
Catheter ablation is an alternative approach. It is a well-established and commonly
used therapeutic option for managing patients with symptomatic AF. It consists of ab-
lating the site of anatomical reentry or fibrillary activity via a catheter that applies ra-
diofrequency current to heat and destroy the tissue. However, this procedure is not
recommended for management of POAF patients after thoracic surgery [66], since: 1)
several factors that promote POAF cannot be addressed simply by this technique [29];
2) it is common for AF to recur in the two- to three-month post-ablation healing phase,
making it an inappropriate strategy for the control of acute, symptomatic AF, such as that
which occurs in the postoperative setting; and 4) its efficacy is modest, and it is associated
with risk of complications [66].
Thromboembolism prevention. Thromboembolic events are one of the most haz-
ardous complications of AF, which can be reduced with anticoagulation. Moreover, oral
anticoagulants at discharge have been associated with a reduction in long-term mortality
in POAF. However, anticoagulation is associated with increased risk of bleeding or cardiac
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tamponade when administered in the postoperative period [67]. Therefore, the indication
and timing of this therapy in POAF patients should take into consideration the risk of
postoperative bleeding. Aspirin is a suitable substitute for patients at low risk of throm-
boembolic events [8]. It is important to note that even though stroke prevention is central
to AF management, data on anticoagulation prophylaxis in the postoperative setting are
significantly lacking, and management is often based on evidence from nonsurgical data
[45].
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Prediction of Postoperative Atrial
Fibrillation: State of the Art
This chapter presents the state of the art on the prediction of postoperative atrial fib-
rillation (POAF). It is divided into two parts: preoperative atrial fibrillation (AF) risk
stratification and postoperative prediction of AF. The first describes risk stratification
efforts to predict POAF using either risk factors, preoperative electrocardiogram (ECG)
features, or both combined. The second contains recent methodologies for analysing the
ECG on a beat-to-beat basis to predict the onset of atrial fibrillation.
3.1 Preoperative AF risk stratification
An important aspect of POAF management is the identification of risk factors, and de-
velopment of accurate prediction models. Risk stratification helps identifying patients
who are most likely to develop POAF, and therefore most likely to benefit from targeted
prophylactic treatment, thereby improving patient outcomes and reducing healthcare
costs.
Several risk scores have been proposed for predicting the development of POAF, based
on common risk factors that are significantly associated with the occurrence of the ar-
rhythmia in their respective derivation cohorts (Table 3.1). Even though the predictive
value of some of the models is reasonably good, they cannot be considered strong models,
limiting their clinical application in risk stratification. Moreover, as in AF unrelated to
surgery [43, 44, 68, 69], increased age is the only characteristic that has been consistently
linked to an increased risk of POAF across all studies [6, 70–73]. The operation type has
also been found to be a risk factor of POAF, although this has not been tested in some
models [70, 71]. Importantly, no risk stratification has been performed in non-cardiac
surgeries, further limiting the generalisability of the models to all surgery types.
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Because structural factors, such as fibrosis, scarring, and dilatation of the atria, are pre-
dispositions to POAF, it has been hypothesized that electrophysiological measurements
before surgery may help predict the development of the arrhythmia. Since then, over 25
ECG features extracted from the either P-wave or heart rate variability (HRV) have been
proposed (Table 3.2). As the P-wave reflects atrial depolarization, the site responsible for
the arrhythmia, it has been the most extensively studied component.
Table 3.1: Risk models for the prediction of incident atrial fibrillation after cardiac
surgery.
Study Model inputs Notes Predic-
tive value:
c-statistic
Mathew
et al. [6]
• Age
• Medical history of AF or COPD
• Valve surgery
• Withdrawal of beta-blockers or
ACE inhibitors
• Beta-blockers or ACE inhibitor
treatment (pre- and/or postoper-
atively)
• Postoperative potassium supple-
mentation or nonsteroidal anti-
inflammatory treatment
• The study also modeled a risk
score for recurrence of AF
and for the complications of
POAF.
0.77
Helgadottir
et al. [72]
• Age
• Operation type
• Standard EuroSCORE
• Patients with preoperative
history of AF were excluded
• No cross-validation was per-
formed.
0.74
Mariscalco
et al. [73]
• Age
• Emergency operation
• Preoperative aortic balloon
• Left ventricular ejection fraction
< 30%
• Glomerular filtration rate <
15mL/min or dialysis
• Heart valve surgery
• COPD
• The modeled POAF score was
also predictive of hospital
mortality.
0.65
Chua et
al. [71]
• CHADS2: congestive heart fail-
ure, hypertension, age> 75 years,
type 2 diabetes, and previous
stroke or transient ischemic at-
tach (doubled).
• CHA2DS2-VASc: congestive
heart failure, hypertension,
age > 75 years (doubled), type
2 diabetes, previous stroke,
transient ischemic attack or
thromboembolism (doubled),
vascular disease, age 65-75 years,
and gender
• These scores were previously
recommended and studied to
guide antithrombotic therapy
in patients with AF or atrial
flutter. Each of the factors
that can lead to atrial enlarge-
ment.
• No validation using the area
under the receiver-operating
curve was performed.
n\a
AF, atrial fibrillation; ACE, angiotensin-converting enzyme; CI, confidence interval; COPD, congestive obstructive pulmonary disease;
ECG, electrocardiogram; ms, milliseconds; n/a, not available; POAF, postoperative atrial fibrillation.
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Even though some of the proposed methods have reached relatively good predictive
values in terms of accuracy (the root mean square of the last 20ms of the signal-averaged
P-wave combined with the signal-averaged P-wave duration provided the best result with
an accuracy of 83% [74]), they are not sufficiently reliable for clinical use. Furthermore,
due to the lack of a standard definition of P-wave onset and offset, P-wave time domain
methods cannot be easily compared [23]. Nevertheless, the results obtained using these
time domain indices are of clinical interest. Frequency domain indices and heart rate
variability metrics have not shown to be useful preoperative predictors of POAF.
Table 3.2: Preoperative electrocardiogram-based methods for prediction of postopera-
tive atrial fibrillation. These include P-wave and heart rate variability features in time,
frequency and time-frequency (wavelet) domain.
ECG-component Feature domain Feature
P-wave
Time
Signal averaged duration [75–77]
Duration [78–85]
Isoelectric interval [76, 80]
Signal-averaged root mean square [74]
Root mean square [84]
Terminal force [76]
Spatial velocity [76]
Dispersion [78, 79, 81–83]
Amplitude [81, 82, 85]
Variance [78]
Area [85]
P-axis [81]
PR interval [81, 85]
Frequency Signal-averaged power [84, 86]
Time-frequency Mean and maximum energy [87]
Heart Rate Variability
Time
Mean [88]
SDRR [88]
rMSSD [88]
NN50 [88]
pNN50 [88]
TINN [89]
Triangular index [88]
Embedded spectral entropy [88]
Frequency LF/HF [88]
Geometric Poincaré dispersion (SD1, SD2) [88]
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3.2 Prediction of atrial fibrillation
Efforts to predict the imminent onset of AF started with the Computers in Cardiology
2001 challenge [90], which had the objective of developing a fully automated method to
classify ECG signals as corresponding to just before the onset of paroxysmal AF or not.
The developed methods mostly focused on the detection of atrial premature complexes
using the inter-beat intervals [91–95] and heart rate variability metrics [91, 96–99], with
a only single approach considering the QRS-complex morphology [96]. Even with a small
dataset, results were insufficient and lacked accuracy (the best study achieved an accuracy
of 80%).
Most recently, studies have investigated beat-to-beat analyses of the ECG during con-
tinuous monitoring, thus enabling real-time clinical prediction of AF. These methods can
be divided into three stages, as depicted in Figure 3.1 and illustrated in Figure 3.2.
Model
estimation
Metric
calculation
Feature
extractionECG
Prediction
of AF
Figure 3.1: The three stages of atrial fibrillation (AF) onset prediction techniques, that
perform beat-to-beat analyses of the ECG. Even though these methods have focused on
the electrocardiogram (ECG) signal, they could also be applied to other signals.
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Figure 3.2: Illustration of the three stages of atrial fibrillation (AF) prediction algorithms.
These techniques start by delineating the electrocardiogram signal and extract features
(e.g. P-wave duration, as depicted). Then, those features are summarised into metrics (e.g.
mean and standard deviation, as depicted, or more complex variability measurements),
that are used to estimate models.
3.2.1 Feature extraction
The feature extraction stage derives a set of features from each beat of the ECG signal.
Most studies have focused on the P-wave’s intervals and morphology.
This stage relies on the identification of the ECG fiducial points. The initial step,
common to all techniques, is the identification of the R peak of the QRS complex [100,
101]. This allows the calculation of several heart rate variability (HRV) metrics. The
delineation of the P-wave was performed either using the dyadic wavelet [102, 103] or
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phasor transform decomposition [104], with both methods showing high delineation
accuracy. The use of such automated delineator allows not only the characterization of
the P-wave, but also mitigates the lack of standard definition of the P-wave onset and end.
Finally, several features are extracted using the P-wave fiducial points and signal.
3.2.2 Metric calculation
The metric calculation step, common to all methods, extracts several indices from each
feature’s time-series over a determined period of time (Table 3.3). This summarises each
time-series of feature measurements as a single metric. Extracted metrics ranged from
simple statistical metrics such as the mean, to more complex variability measurements.
3.2.3 Model estimation
This final step makes use of the previously calculated metrics to create a model to assess
the likelihood of developing AF. Studies have relied on machine learning approaches,
using the statistically significant metrics as inputs to the algorithms (Table 3.3).
Even though these studies have shown interesting and positive results, they rely on
relatively small populations. Furthermore, the majority of the studies have based their
models on signals from a time-frame too close to the onset of AF, which would not
provide sufficient warning time for prophylactic treatment to be administered and take
effect. Nonetheless, these studies have achieved encouraging results.
Overall, the beat-to-beat analyses have studied the variability of the extracted ECG
features, and have obtained high prediction performance (with accuracy ranging from
70% and 100%). These studies have found that patients who will develop AF have greater
variability in P-wave morphology and time-intervals (Figure 3.3) [25–27, 105, 107, 108],
and that this variability increases as the onset approximates [25, 26, 105, 107, 108]. These
subtle P-wave alterations are according to the atrial electrophysiological changes that
precede AF, and suggest intermittently disturbed atrial conduction in patients close to
start of the arrhythmia [25].
3.3 Conclusion
Prediction of POAF is preferable in the preoperative period because it allows the adminis-
tration of drugs earlier. Indeed, the 2016 ESC guidelines recommend the administration
of beta-blockers or amiodarone in the perioperative period [55]. However, results in pre-
operative risk stratification are limited. In contrast, recent studies have indicated that the
prediction of POAF in the postoperative period is more promising, as these researches
have obtained greater prediction performances (Table 3.3).
Even though considerable progresses have been achieved in the postoperative predic-
tion of AF, no technique reliable for autonomous clinical integration has been proposed
yet. Further work is required to improve the prediction of POAF from continuous and
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Table 3.3: Studies that have performed beat-to-beat analyses of the electrocardiogram for
predicting several types of atrial fibrillation, which would be suitable for use in continu-
ous postoperative monitoring.
Study
Cohort
dimension
Time before
AF onset
ECG
features Used metric
Model
(accuracy)
Martinez
et al. [25]
24 PAF +
28 healthy
2h • P-wave intervals
• Heart rate
Linear regression
slope of the vari-
ability
Linear dis-
criminant
(90.8 %)
Martinez
et al. [26]
46 PAF +
53 healthy
2h • P-wave morphol-
ogy: area, con-
duction velocity,
arc-length
Linear regression
slope of the vari-
ability
Decision tree
(863%)
Martinez
et al. [105]
46 PAF +
53 healthy
2h • Gaussian fit pa-
rameters (A,C, W)
and error
Linear regression
slope of the vari-
ability
Stepwise dis-
criminant
analysis
(86.7 %)
Sovilj et al.
[24]
14 POAF +
36 healthy
48h after
CABG
• P-wave intervals
• Heart rate
• Wavelet energies
and entropy
Cumulative rank
with statistically
significant features
Decision
tree [ap-
plied over the
time-course]
(85.3 %)
Ovreiu et
al. [106]
37 POAF +
53 healthy
30m • Number of prema-
ture atrial com-
plexes
• HRV: mean,
SDRR, rMSSD, to-
tal power, LF/HF,
entropy
• P-wave duration,
amplitude, shape,
inflection point,
energy ratio
Mean value Neuro-fuzzy
(70.0 %)
Martinez
et al. [107]
46 PAF 2h • P-wave intervals
• P-wave area, arc-
length
Central tendency
measurement
Decision tree
(90.0 %)
Alcaraz et
al. [108]
46 PAF +
53 healthy
2h • P-wave frequency
energies
Linear regression
slope of the vari-
ability
Stepwise dis-
criminant
analysis
(80.0 %)
Censi et al.
[27]
73 pers.
AF + 20
healthy
n/a • P-wave duration
and dispersion
• P-wave morphol-
ogy: polarity
changes, frag-
mented conduc-
tion index
• P-wave variabil-
ity: amplitude
dispersion index,
correlation coeffi-
cient, DTW
Mean value Receiver oper-
ating charac-
teristic curves
(without cross-
validation)
(100.0 %)
AF, atrial fibrillation; CABG, coronary artery bypass grafting; PAF, paroxysmal atrial fibrillation; POAF,
postoperative atrial fibrillation; pers., persistent; n/a, not available; DTW, dynamic time warping.
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95ms94ms 94ms 94ms 96ms 94ms 95ms
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Healthy subject
Patient before paroxysmal atrial brillation
Figure 3.3: Example of representative ECG signals corresponding to healthy sujects (top)
and patients susceptible to paroxysmal atrial fibrillation (PAF; bottom). Patients who will
develop PAF are characterised with higher variability in P-wave duration (and other time
and morphological features) than healthy subjects. Adapted from Alcaraz et al. [109].
unsupervised monitoring in the clinical setting. Specifically, at least three aspects need
to be considered:
1. Systematic comparison of predictive methods. Although the majority of the pro-
posed predictive techniques have achieved high accuracy, it is not clear which
method, if any, is most suitable for clinical use. Moreover, it would be useful to in-
vestigate whether combining multiple indices provides improved prediction ability.
2. Evaluation of predictive methods in clinically useful scenarios. The majority of
studies have studied the two hours before the onset of AF, which might be too late for
prophylaxis. Furthermore, these studies have only used ECG signals during sinus
rhythm, not having considered other rhythms that are common in the postoperative
period, such as tachyarrhythmias or bradyarrhythmias [110]. Hence, it is necessary
to test the prediction of POAF under clinically relevant and useful scenarios that
mimic the real world clinical setting, and at a time before POAF where it is still
possible to administer efficient prophylactic treatments.
3. Adaptation for unsupervised use during continuous monitoring. ECG data, espe-
cially when acquired during continuous monitoring, is susceptible to several arte-
facts that can lead to inaccurate measurements and consequently to a high number
21
CHAPTER 3. PREDICTION OF POSTOPERATIVE ATRIAL FIBRILLATION:
STATE OF THE ART
of false alarms. This is particularly important in P-waves, which are highly suscepti-
ble to noise. Most studies have excluded noise-corrupted P-waves manually, which
is not feasible in the clinical setting. Hence, the development of an automated P-
wave quality assessment tool to discriminate between high quality and unreliable
P-waves is needed to ensure the accuracy of techniques that predict AF.
Hence, several important aspects need to be considered so that the prediction of AF
might be performed in the unsupervised clinical setting.
22
C
h
a
p
t
e
r
4
P-wave Quality Index
This chapter presents and assesses the utility of the P-wave Quality Index (PQI), a tool
which automatically identifies artefact-corrupted P-waves. Firstly, the PQI tool is de-
scribed, and three different versions are proposed. The performance and utility of each
of the three was assessed, and the version showing the highest performance and utility
was selected to constitute the final PQI tool. Performance was assessed using its ability
to discriminate between high and low quality data. Utility was assessed using: 1) mean
absolute error comparisons of several well-known P-wave features with and without the
PQI; and 2) evaluation of performance for predicting atrial fibrillation (AF) by using
metrics extracted from the P-waves with and without the PQI.
4.1 Introduction
Long-term continuous monitoring using wearable devices has enabled early identification
of several types of arrhythmia. A challenge to the use of long-term monitoring, where
data is normally collected without clinical supervision, is ensuring that only high quality
signals are used to derive clinical measurements. Physiological parameters extracted
from artefact-corrupted signals may be inaccurate, which can lead to a high frequency
of false alarms [111]. Therefore, assessment of signal quality is a crucial step before
accurate and precise data analysis, such as extracting features, identifying deteriorations,
and generating alerts.
The study of P-waves from surface electrocardiogram (ECG) is especially important in
atrial arrhythmias, such as AF. For instance, subtle alterations in P-wave morphology have
been found to be predictive of AF [23, 25–27]. The relatively low amplitude of the P-wave
makes it highly susceptible to noise, severely affecting the extraction and quantification
of its features, and hindering its clinical applications, especially in long-term recordings.
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As artefact-corrupted P-waves influence derived measurements, it is essential to ex-
clude them. This has been performed either manually, where expert cardiologists ex-
cluded unreliable P-waves by hand [25, 26], or automatically, with a conventional template-
comparison method [112]. In the latter, individual P-waves were discarded if they had a
cross-correlation coefficient lower than 0.7 with a template P-wave obtained with an av-
eraging procedure [27]. Despite being promising, the methodology was not described in
depth, and the threshold used to identify low quality P-waves was not optimized, limiting
its reproducibility and utility.
Currently, even though much focus has been placed in the creation of methods that
use P-waves to predict atrial arrhythmias, there is no reliable tool that assesses P-wave
quality automatically. Thus, the clinical utility of such methods could be highly limited
by parameters being estimated erroneously from low quality P-waves, causing false alerts.
We propose a novel P-wave quality assessment tool to discriminate between high quality
and unreliable P-waves, and assess its performance and utility on a database of wearable
ECG recordings.
4.2 Methods
4.2.1 Data description
The Computers in Cardiology 2001 challenge database (AFPDB) [90, 113] was used to de-
velop and assess the performance of the PQI [90]. This database was originally assembled
with the aim of developing techniques for predicting paroxysmal AF (PAF). It consists
of a learning and testing set, both of 100 records, with each record lasting 30 minutes.
All signals have a sampling frequency of 128Hz and a 12-bit resolution. The database
contains three different subject types: healthy controls, PAF patients far away from the
arrhythmia onset (no episode 45 minutes before or after the record), and PAF patients
just before the arrhythmia onset.
Forty four records (23 from controls and 21 from PAF patients) were randomly se-
lected from the training select, after exclusion of those records which did not have dis-
cernible P-waves. After pre-processing with a bandpass filter with cut-off frequencies
of 0.5 and 40Hz, the ECG lead in which P-waves were most visible for each record was
chosen, and P-wave quality was manually annotated and double-checked. Following the
tool’s methodology (described bellow), P-waves were classified into three distinct classes,
as illustrated in Figure 4.1.
Class A: High quality clean P-waves;
Class B: Complete noise and absent P-waves. This included P-waves with no resemblance
to normal P-wave morphology, either due to motion artefacts, severe baseline wan-
der, muscular activation interference, or simply the absence of a P-wave;
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Class C: Unreliable, noise-distorted P-waves. This included P-waves that had some resem-
blance to normal P-wave morphology, but were still unreliable (i.e., their morphol-
ogy was still excessively affected by noise). The degree of distortion varied from
mildly to heavily distorted (see Figure 4.1).
This resulted in 22 hours of recording, corresponding to 97,989 P-waves: 88,606 class
A (90.4%), 5,102 class B (5.2%), and 4,281 class C (4.4%). PAF patients had a higher
proportion (p<0.05) of class B P-waves than controls, as compared using a two-sample
t-test.
Class A: 
Clean P-waves
Class C:
Noise-distorted P-waves
Class B: 
Complete noise
Increasing distortion
Figure 4.1: P-waves were classified into three different classes: high quality clean P-waves
(class A), complete noise or absent P-waves (class B), and unreliable, noise-distorted P-
waves (class C). Even though class C P-waves had some resemblance to normal P-wave
morphology, they were still considered unreliable. For that class, the degree of distortion
varied from mildly to heavily distorted.
4.2.2 P-wave Quality Index algorithm
The PQI tool algorithm is depicted in Figure 4.2. Briefly, the process started with P-wave
detection and signal extraction, and was followed by two different decision-making stages
based on template-comparisons. The first decision stage aimed to remove P-waves with
no resemblance to the normal P-wave morphology (class B), while the second was more
refined, removing P-waves still excessively distorted by noise, and hence unreliable (class
C).
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Removal of
class B P-waves
P-wave signal
extractionECG
P-wave quality
assessment
Decision Stage 1
Removal of
class C P-waves
Decision Stage 2
Figure 4.2: The P-wave quality index (PQI) tool consisted of three steps. In the first, the
P-waves were identified and extracted. These signals were then used to create P-wave
templates and to extract features, which were used in two different decision-making
stages. At the end of the PQI, P-waves distorted by noise, and hence unreliable, were
expected to be excluded from the analysis.
4.2.2.1 P-wave signal extraction
The first step towards assessing the P-waves’ quality was to detect them in the ECG and
extract them. This signal extraction step was of high importance, as the following PQI
algorithm stages relied on the accurate segmentation of the P-waves. Hence, a proper
P-wave quality assessment was only possible with a proper P-wave signal extraction. In
order to extract the P-wave, its peak was first identified. To do so, first, each R-peak
was identified using the widely used Pan, Hamilton and Tompkins algorithm [100, 101],
followed by Q-wave and P-wave peak delineation using the phasor transform delineation
algorithm [104] (see Section 5.2.2 for detailed explanation).
Finally, P-wave signals were then extracted by taking a window of width 300ms, cen-
tred on the correspondent P-wave peak. This window length ensured that the whole
P-wave plus its surrounding baseline signal were captured. Any windows containing the
correspondent Q-wave were shortened to just before that point.
4.2.2.2 Decision stage 1: Removal of completely noisy P-waves
The aim of the first decision-making stage was to exclude P-waves which were heavily
distorted, either due to motion artefacts, severe baseline wander, muscular activation
interference, or simply by the absence of a P-wave (class B). This first stage had the
additional purpose of removing P-waves that could influence the more refined templates
created during the second decision-making stage.
P-waves within a 30-minute period were aligned, and a P-wave template was created in
an iterative process. Before the alignment process, differences in P-wave signal durations
due to different PQ intervals and/or imperfect Q-wave delineations were accounted for
by further shortening the windows’ end so that it was not exceeded by more than 30% of
the individual windows’ end.
The alignment process allowed each individual P-wave signal to be aligned with a tem-
plate. This template started as the second P-wave, and was updated for every subsequent
P-wave. Hence, the template used to align a given P-wave corresponded to the average of
all the previous aligned P-waves. The optimum alignment was that which maximized the
Pearson correlation coefficient between the P-wave and template, being allowed a maxi-
mum shift from the original position of 50ms. Given that signals were always pre-aligned
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by their peak, this maximum shift aimed to ensure that only physiological variations
were present, averting unnecessary overfitting with noise. As illustrated in Figure 4.3,
this alignment process was of utmost importance, especially for fragmented P-waves.
P-wave #1
P-wave #2
P-wave #3
P-wave
template
Misaligned Aligned
Figure 4.3: Proper P-wave alignment was essential for an optimal P-wave template cre-
ation. When P-waves are aligned by their peak (left), the correspondent created template
can fail to represent the associated P-wave morphology. This is due to variations in P-wave
peak identification, which can cause P-waves to be misaligned. As depicted, this effect is
especially dangerous in fragmented P-waves where P-wave peak delineation varies greatly.
However, with proper P-wave alignment (right), the template creation is optimized.
After all the P-waves were aligned with the corresponding template, several features
were extracted in order to retrieve information about them. These features were then
used as candidate features for the PQI to assess P-wave quality. The following features
were tested:
1. P-wave template comparison features:
a) Pearson’s correlation coefficient between P-wave and template [114];
b) Root mean square (RMS) difference between P-wave and template;
c) Pearson’s correlation coefficient between P-wave and template derivatives;
d) Root mean square difference between P-wave and template derivatives.
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2. P-wave signal features:
a) Standard deviation of P-wave [115];
b) Number of zero-crossings of P-wave [115];
c) Area of P-wave;
d) Kurtosis of P-wave [111];
e) Skewness of P-wave [111];
f) Standard deviation of P-wave derivative.
The ability of the aforementioned features to discriminate between class A and class
B P-waves was assessed through comparisons with the manual annotations. Performance
was quantified using the receiver operating characteristic (ROC) curve, and features with
an area under the curve (AUC) greater than 0.75 were selected be included in the final
decision stage 1 model. This model consisted of a decision tree and its performance was
assessed using 10-fold cross validation. During the analysis, class A clean P-waves were
considered as the positive class.
4.2.2.3 Decision stage 2: Removal of distorted P-waves
Having removed the completely distorted P-waves, more refined P-wave templates could
be created. This was then used in a final decision stage with the aim of removing dis-
torted and unreliable P-waves (class C), while being able to accommodate possible P-wave
morphological variations.
This second decision stage was similar to the first, but with the single difference that
P-waves were aligned and a template created every few (n) P-waves (instead of every 30
minutes), aiming to accommodate both ECG physiological variations along time (Figure
4.4) and the greater P-wave variability that precedes AF [25–27]. The value of n was varied
from 10 to 100 and the number which gave the best overall feature results was selected
and used to build the final model. Similarly to the first decision-making stage, the same
features were extracted and their selection process used the same criteria. Finally, two
decision trees were assembled - one promoting balanced (i.e., assigning equal importance)
sensitivity and specificity, and the other favouring high sensitivity.
4.2.3 P-wave Quality Index performance and utility assessment
Once the PQI decision-making models were built, three different versions of the PQI tool
were assembled:
PQI Stage 1: Using only Decision Stage 1;
Balanced PQI: Using Decision stage 1, plus Decision Stage 2 with balanced sensitivity
and specificity;
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Figure 4.4: P-wave morphology variation over time due to physiological variations. The
extracted P-wave signal (dotted box) starts by being asymmetrical and containing the
T-wave from the previous beat, and ends up symmetrical and containing the surrounding
baseline.
Sensitive PQI: Using Decision stage 1, plus Decision stage 2 with high sensitivity.
In order to select the best suited version of the PQI tool, the classification performance
and two aspects of their utility were compared:
1. Classification performance (i.e., the ability to distinguish between high and low
quality P-waves) assessment of each PQI version on the entire 44 records. Class A
clean P-waves were again considered as the positive class, while classes B and C
were merged into one unique negative class.
2. Mean absolute error (MAE) comparisons between P-wave features obtained from
all the recorded P-waves, and only from those classified as high quality by each PQI
tool version. Clinical features included the mean and standard deviation of P-wave
duration, amplitude, area and arc-length, as they have shown to give important
insights on atrial conduction [23, 26]. Reference values of P-wave features were
obtained from P-waves which were manually annotated as high quality.
3. Evaluation of performance for predicting PAF. Several features were extracted from
the P-waves (see Table 5.1 from Chapter 5), resulting in feature time-series, from
which a selection of metrics were calculated (see Table 5.2). Next, statistical sig-
nificance (Mann-Whitney) tests were used to evaluate the ability of the extracted
metrics to distinguish between the three different subject groups (Healthy, PAF far,
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and PAF close), resulting in each metric being identified as either significantly differ-
ent between groups, or not significantly different. This process was performed four
times: using the manually annotated high quality P-waves, and using the P-waves
labelled as high quality by each of the three versions of the PQI tool. An evaluation
of performance for predicting PAF was performed for each version of the PQI by
testing if the set of significant metrics obtained was similar to the set obtained when
using the manual annotations. This was performed using the sensitivity and speci-
ficity statistics, which were calculated by comparing the significance of the metrics
obtained from each version of the PQI tool with the significance of the metrics ob-
tained from the manually annotated P-waves. Significant metrics (p<0.05) were
considered the positive class, while non-significant metrics (p≥0.05) constituted
the negative class. Tested metrics included the mean, standard deviation (both on
entire records and on a 5-minute basis), and variability (linear and non-linear) mea-
surements of several P-wave features (refer to Section 5.2.4 for more details), which
have been shown to be predictive of AF.
Once the best PQI version was selected, two additional quality assessments were
performed. Firstly, it was tested whether the P-wave quality classification performance
of the final PQI tool differed between controls and PAF patients. This was performed
by comparing the individual classification performance of the two groups using a two-
sample t-test. Secondly, the ability of the final PQI tool to separately distinguish class A
from class B (class A vs. class B) and class A from class C (class A vs. class C) P-waves was
assessed on the entire 44 records.
Throughout all the mentioned P-wave quality classification performance assessments,
only the sensitivity and specificity metrics were used, as they have the advantage of
being independent to class distributions [116, 117], and therefore are able to provide
comprehensive assessment of imbalanced learning problems [118], such as the present
one.
4.3 Results
4.3.1 Decision stage 1: Removal of completely noisy P-waves
Table 4.1 shows the performance of each separate feature, measured using the AUC, on dis-
criminating class A from class B P-waves. The following features had AUCs greater than
0.75, and were therefore used to estimate the decision-making stage 1 model: template
correlation, template RMS error, template derivative correlation, and P-wave skewness.
A decision tree was built using the aforementioned features. Given the high imbal-
ance between classes, this model was built assuming both classes’ probability as equal,
allowing one to balance sensitivity and specificity. Furthermore, the decision tree had a
maximum of 5 splits (i.e. decisions), in order to avoid overfitting. Figure 4.5 shows the
obtained decision tree, and Table 4.2 shows its performance measured using 10-fold cross
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Table 4.1: P-wave quality assessment features, and corresponding area under the curve
(AUC) for both decision-making stages. Decision stages 1 and 2 aimed to distinguish class
A from class B P-waves, and class A from class C P-waves, respectively.
Area under the curve
Decision stage 1 Decision stage 2
P-wave template comparison features
Template correlation 0.96 0.89
Template RMS difference 0.96 0.85
Template derivative correlation 0.92 0.83
Template derivative RMS difference 0.73 0.71
P-wave signal features
Standard deviation 0.67 0.69
Zero crossing number 0.56 0.62
Area 0.60 0.54
Kurtosis 0.61 0.57
Skewness 0.76 0.66
Derivative standard deviation 0.64 0.78
RMS, root mean square.
Table 4.2: Performance of decision-making stage 1 on distinguishing class A from class B
P-waves, and performance of each version of decision stage 2 to distinguish class A from
class C P-waves.
Sensitivity Specificity
Decision Stage 1 0.94 0.96
Decision Stage 2
Balanced version 0.83 0.89
Sensitive version 0.99 0.22
validation. Note that, even though the skewness feature had shown good discrimination
ability, it was not included in the decision tree.
4.3.2 Decision stage 2: Removal of distorted P-waves
Several P-wave groupings were tested in order to maximise discernment between class
A and class C P-waves. Keeping in mind that increasing window duration (n) has the
disadvantage of increasing time between consecutive windows, due to gaps in the data
[119], and balancing with the obtained AUCs (Figure 4.6), n was set to be 20 P-waves.
When distinguishing between class A and class C, the features template correlation,
template RMS error, derivative template correlation and P-wave derivative standard de-
viation had AUCs greater than 0.75 (Table 4.1). Two different decision trees were built
using those features, both with a maximum of 5 splits (Table 4.2): one favoured balanced
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Clean NoiseNoise
Clean Noise
Tcorr < 0.88
dTcorr < 0.68 Trmsd < 0.09
Trmsd < 0.06
Tcorr >= 0.88
dTcorr  >= 0.68 Trmsd >= 0.09
Trmsd >= 0.06
Figure 4.5: Final decision-making stage 1 decision tree. This model made use of the
following features to discern clean from complete noise/absent P-waves: template cor-
relation (Tcorr), template root mean square difference (Trmsd), and template derivative
correlation (dTcorr).
sensitivity and specificity and was used in the Balanced PQI version, while the other
promoted high sensitivity (Figure 4.7) and was used in the Sensitive PQI version.
4.3.3 P-wave Quality Index performance and utility assessment
After the three different versions of the PQI tool (PQI Stage 1, Balanced PQI, and Sensitive
PQI) were assembled, their classification performance and utility were assessed in order
to select the best suited version:
1. Classification performance assessment (Table 4.3). Overall, the PQI Stage 1 and
Sensitive PQI versions had high sensitivity and good specificity, while the Balanced
PQI had high specificity and good sensitivity. The Sensitive PQI version had the
best sensitivity/ specificity relationship.
Table 4.3: Classification performance (i.e., ability to distinguish between high quality
(class A) and low quality (classes B and C) P-waves) of each version of the PQI tool.
Sensitivity Specificity
PQI Stage 1 0.93 0.77
Balanced PQI 0.77 0.98
Sensitive PQI 0.93 0.82
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Figure 4.6: Area under the curve (AUC) in function of number of P-waves grouped in order
to create a P-wave template, n. The value of n was set to 20 P-waves by balancing between
high AUC and window length. The features template correlation (Tcorr), template root
mean square difference (Trmsd), and template derivative correlation (dTcorr) are here
represented given their AUC greater than 0.75.
Clean
Distorted Clean
dPstd < 0.06
Tcorr < 0.95
dPstd >= 0.06
Tcorr >= 0.95
Figure 4.7: Final decision-making stage 2 decision tree, correspondent to the Sensitive
PQI tool version. This model made use of the following features to distinguish clean
and noise-distorted P-waves: standard deviation of P-wave derivative (dPstd) and P-wave
template correlation (Tcorr).
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2. MAE comparisons (Table 4.4). Overall, the Sensitive PQI version outperformed the
remaining by having the smallest MAE, while the Balanced PQI had the highest
MAE across the majority of the tested metrics. Figure 4.8 shows, for each record, the
difference in MAE for the mean P-wave duration using the Sensitive PQI version (i.e.
the MAE obtained using the P-waves obtained with Sensitive PQI subtracted from
the MAE using all P-waves), representing a case where the Sensitive PQI brought
an intermediate improvement on feature assessment.
3. PAF prediction analysis comparisons (Table 4.5). The Sensitive PQI version outper-
formed the remaining in terms of sensitivity/ specificity relationship throughout
most of the tested methods. Furthermore, the analysis using all the P-waves con-
tained in the recordings was found to have the greatest total sensitivity, driven by
the non-linear variability method.
Table 4.4: Utility of each version of the P-wave quality index (PQI) tool assessed with
mean absolute error (MAE) comparisons between P-wave features obtained using all the
available P-waves and those labelled as high quality by each version of the PQI tool.
The presented factor represents how many times the given method reduced the MAE in
comparison to when using all the P-waves.
Mean Absolute Error
All PQI Stage 1 Balanced PQI Sensitive PQI
P-wave features Metrics Error Error Factor Error Factor Error Factor
Duration [ms]
Mean 2.63 0.55 4.8 1.04 2.5 0.50 5.3
SD 3.26 0.39 8.4 0.68 4.8 0.34 9.4
Amplitude [mV]
Mean 5.73 1.85 3.1 0.28 2.0 0.17 3.4
SD 0.24 0.03 7.2 0.05 5.3 0.04 7.0
Area [µVs]
Mean 0.04 0.01 3.2 0.02 2.5 0.01 3.3
SD 0.19 0.02 8.1 0.03 6.0 0.02 7.9
Arc-length [µVs]
Mean 0.34 0.07 4.8 0.13 2.5 0.06 5.3
SD 0.42 0.05 8.4 0.09 4.8 0.04 9.3
SD, standard deviation.
Given that the Sensitive PQI version outperformed the others in classification perfor-
mance and in both utility assessments, it was chosen to constitute the final PQI tool and
will be, from now on, referred only as "PQI".
Finally, the ability of the final PQI tool to separately distinguish class A from class B
(class A vs. class B) and class A from class C (class A vs. class C) P-waves was assessed
on the entire 44 records, and overall performance between controls and PAF patients
was compared (Table 4.6). Class B P-waves were removed with extremely high specificity
(0.97), while class C P-waves were removed with low specificity (0.64). Furthermore,
no statistically significant difference (p<0.05) was found in sensitivity nor specificity be-
tween the PAF and control groups, even though the controls had a lower mean specificity
value. When inspecting performance in an inter-individual fashion, 4 records (3 from
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Table 4.5: Utility of each version of the P-wave quality index (PQI) tool assessed by
evaluating their performance for predicting paroxysmal atrial fibrillation (PAF). This
was performed by testing if the significance of the computed predictive metrics was
correct, using the sensitivity and specificity statistics. The metrics used to predict PAF
are explained in detail in Section 5.2.4.
Sensitivity/ Specificity
Method All PQI Stage 1 Balanced PQI Sensitive PQI
Feature’s mean, SD, and
time course
0.64/ 0.96 0.82/ 0.99 0.80/ 0.98 0.86/ 0.99
Linear variability and
time course
0.31/ 0.78 0.70/ 0.92 0.52/ 0.94 0.68/ 0.92
Non-linear variability
(CTM)
0.31/ 0.74 0.22/ 0.92 0.11/ 0.68 0.24/ 0.92
Total 0.22/ 0.63 0.16 /0.88 0.08/ 0.59 0.18/ 0.88
CTM, central tendency measurement; SD, standard deviation.
controls and 1 from a PAF patient) had a specificity lower than 0.5 (Figure 4.9). From
those, one had a null specificity due to the existence of only two noisy P-waves on the
entire recording, another also had a very low percentage of low-quality P-waves, and the
remaining two were constituted mostly by class C P-waves with a low level of distortion.
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Figure 4.8: Differences in mean absolute error (MAE) between P-wave mean duration
calculated when using all the P-waves and when using those obtained with the final P-
wave quality index (PQI) tool (correspondent to the Sensitive PQI version). A positive
difference indicates an improvement of MAE when using the proposed PQI tool.
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4.4 Discussion
The future implementation of techniques that make use of the P-wave to predict atrial
arrhythmias, such as AF, will highly rely on proper P-wave quality assessment. Currently
there is no reliable tool that allows to discard noise-corrupted P-waves, despite its impor-
tance. In the present chapter we proposed the PQI, a novel tool capable of automatically
identifying noise-corrupted, and hence unreliable, P-waves.
Briefly, the algorithm starts by detecting and extracting the P-waves’ signal, which
is then used in two decision-making stages: the first with the aim of removing highly
noisy or absent P-waves, and the second with the aim of removing less distorted, but still
unreliable, P-waves. We have shown the PQI tool to have a positive clinical impact by
reducing the error of commonly used P-wave features and by improving the ability to
predict AF. Finally, we have shown the PQI to perform equally well on healthy subjects
and patients who will develop PAF, further indicating that the proposed tool was able to
accommodate the P-wave variability that precedes AF [25–27].
Table 4.6: Comparison between individual P-wave quality classes (class A vs. Class B and
Class A vs. Class C P-waves), and comparison of overall classification performance (class
A vs. classes B and C) between controls and patients who developed atrial fibrillation.
Comparison between
P-wave quality classes
Comparison of overall performance
between subject groups
Statistic
Class A vs.
Class B
Class A vs.
Class C
Total Controls AF patients P-value
Sensitivity 0.93 0.93 0.93 0.92 0.95 0.33
Specificity 0.97 0.64 0.82 0.76 0.86 0.08
AF, atrial fibrillation; class A, clean P-waves; class B, complete noise/ absent P-waves; class C, unreliable,
noise-distorted P-waves.
The proposed tool was built using a large dataset containing almost 100,000 manu-
ally annotated P-waves (corresponding to 22 hours of recording) across several different
morphologies, and trialled 10 different P-wave quality assessment features, some of them
novel. In addition, the proposed tool was built using simple decision tree models, making
it more likely to work in other environments than the current one.
In this study, three different versions of the PQI tool were proposed: one using only
the first decision stage (PQI Stage 1), and two other using the complete PQI tool, but
using the second decision stage with balanced sensitivity and specificity (Balanced PQI)
and high sensitivity (Sensitive PQI). The Sensitive PQI version was found to be the best
performing (in terms of utility), followed by the PQI Decision Stage 1 and the Balanced
PQI. Even though the Balanced PQI was the version with the highest P-wave quality
classification specificity (0.98), it ended up being the least useful one. This can be ex-
plained by the not-so-high sensitivity (0.77): clean P-waves with different characteristics
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Figure 4.9: Individual performance to classify overall P-wave quality (class A vs. classes B
and C), using sensitivity (top) and specificity (bottom), of the P-wave quality index (PQI)
tool on controls (left) and patients (right). Records with performance lower than 0.5 are
highlighted in red.
(e.g. duration) ended up being removed (especially in the more rigorous second deci-
sion stage), prejudicing both the MAE and PAF prediction analyses, as those P-waves
contained important and useful information.
During the PAF prediction analyses, the analysis conducted using all the P-waves
from the recordings was found, surprisingly, to have the best PAF-prediction sensitivity
(Table 4.5). Since this result was driven by the non-linear variability metrics, this is
likely explained by the higher proportion of complete noise/absent P-waves present in
PAF patients, given that features extracted from noisy P-waves are associated to higher
variability. Nonetheless, the specificity value obtained for this particular analysis was
low, reflecting a clear example where noisy P-waves affect data analysis by leading to a
high number of false alarms.
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It is important to note that, even though the Sensitive PQI version (i.e. the final PQI
tool) had lower specificity in the second decision stage, the majority of the more-distorted
class C P-waves were removed during both decision stages, while mildly-distorted (but
still labelled as unreliable) class C P-waves were retained (hence the overall 0.64 speci-
ficity; Table 4.6). Given that the more-distorted class C P-waves were more different
from the clean P-waves than the mildly-distorted class C P-waves, they were more easily
identified. Hence, the remaining class C P-waves that were labelled as high quality (false
positives) probably did not affect the analysis excessively.
A way in which specificity could be increased in the future is with the previous char-
acterization of the signal being analysed in terms of either signal-to-noise ratio (SNR)
or lead configuration, hence allowing to adapt the decision rules to specific signals. In
addition, it is also important to note that the P-wave’s quality annotation procedure was
associated to some subjectivity while separating clean from mildly, yet considered unre-
liable, P-waves. Nonetheless, as noted, in the proposed tool, those P-waves were likely
labelled as of high quality.
Finally, the proposed tool can work on a near real-time basis, an important feature of
quality assessment tools aimed to be used during continuous monitoring. Even though
the PQI requires 30-minute signal portions, such time precision is enough to predict and
act upon atrial arrhythmias such as AF.
4.4.1 Limitations and Future Work
4.4.1.1 P-wave signal extraction and template creation
The proposed tool assumes that, during the creation of a P-wave template each 30 minutes,
noise is cancelled out and, therefore, the obtained signal reflects a clean P-wave. How-
ever, during long term continuous monitoring this may not be the case, as there is the
possibility that the recording may be highly corrupted by noise during a good portion of
time (e.g. during poor electrode contact with the skin), thus causing the obtained P-wave
template to be distorted, and hence affecting severely the tool’s performance. This can
be safeguarded in future works with the addition of a template-verification stage where,
for example, the obtained template signal could be compared with a Gaussian function.
Another important case where the P-wave template might be distorted is during AF, as
there is an absence of P-waves. This particular issue can be addressed in the future with
the use of AF arrhythmia detection algorithms, which would then trigger a modification
in the template creation procedure.
Furthermore, during the creation of template P-waves, it is assumed that the signal
has a single P-wave morphology, thus ignoring the possibility of a secondary P-wave mor-
phology. Recently, a study has found that an increased number of P-waves matching a
distinct secondary morphology was significantly associated with PAF, possibly indicating
different conduction routes on the atrial myocardium [120]. If those secondary morpholo-
gies significantly differ from the main morphology of the created template, they will
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probably be classified as noise and hence discarded from the analysis. Thus, future im-
provements on P-wave quality assessment could include the possibility of an additional
P-wave morphology with, for example, the creation of two different P-wave templates
that could then be used to extract P-wave features and assess its quality.
4.5 Final Remarks
In this chapter we presented the P-wave Quality Index - a novel tool capable of automat-
ically rejecting noise-corrupted P-waves - and showed its positive impact and utility on
P-wave feature assessment and AF prediction. This tool will be particularly important
with the future clinical implementation of AF prediction methods, since the reliability of
P-wave measurements is of utmost importance for their accuracy.
The final proposed tool was able to exclude artefact-corrupted P-waves with a high
sensitivity (0.93) and good specificity (0.82). Furthermore, the tool allowed for more pre-
cise measurements of several well-known P-wave features, and improved the prediction
of AF, especially when using P-wave variability methods.
The P-wave Quality Index tool Matlab® code and P-wave’s quality assessment dataset
are being made publicly available at http://github.com/diogotecelao/PwaveQualityIndex.
These resources allow future researchers to apply the tool in their studies, reproduce the
analyses herein presented, and to use the dataset for additional studies.
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Prediction of Paroxysmal Atrial
Fibrillation: Computers in Cardiology 2001
Challenge
This chapter presents a study on the prediction of paroxysmal atrial fibrillation (PAF).
The aim of this study was to identify subjects at risk of developing PAF, and to predict
the imminent PAF onset in patients known to be at risk. Several electrocardiogram (ECG)
features and metrics, mostly derived from the P-wave, were extracted. The P-wave Quality
Index tool (PQI; presented in Chapter 4) was used to automatically eliminate low-quality
P-waves from the analysis. Finally, the ability of the extracted indices to predict PAF was
studied. In this study, a selection of previously proposed methods were compared, and it
was tested if their combination improved prediction of AF.
5.1 Introduction
Atrial fibrillation (AF) is the most common cardiac arrhythmia disorder [1], with its
incidence expected to increase exponentially [11, 32, 33]. The most serious complications
of AF include stroke, thromboembolic events, and heart failure. Furthermore, AF leads
to electrophysiological modifications within the atria, such as electrical, contractile, and
structural remodeling, which reduces the probability of AF termination [26], and favours
the progression of PAF into persistent AF [121].
The development of accurate predictors of AF is clinically important because preven-
tive as well as more effective treatments may by used to avert the loss of sinus rhythm.
Consequently, the possibility of electrical stabilization and non-recurrence of AF in-
creases greatly [25]. Furthermore, maintenance of sinus rhythm can reduce patients’
risks and symptoms, improve hemodynamics, and decrease the possibility of recurrence
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of AF [25].
The 2001 Computers in Cardiology (CinC) challenge had two major goals: to identify
subjects at risk of developing PAF (event 1), and to predict the imminent PAF onset in
patients known to be at risk (event 2). This challenge has stimulated research on the
prediction of PAF by making a database with the pertinent electrocardiogram (ECG)
recordings publicly available, and has provided a way in which researchers can bench-
mark their methods.
Intensive efforts have been made in the last decade to identify predictors of AF from
the ECG. Several ECG features and metrics have been proposed. However, further investi-
gation of these methodologies is required to determine their clinical utility. Furthermore,
a systematic comparison of the methods has not been performed. Moreover, the combina-
tion of several indices may provide improved prediction performance. Finally, previously
proposed methods were assessed using high quality ECG signals, and have not been
assessed in an unsupervised fashion.
In this chapter we present a study on the prediction of PAF, in which the 2001 CinC
challenge was followed. The aim of this study was to assess the performance of several
methodologies to predict PAF when applied to an unsupervised clinical setting, along
with the previously proposed PQI tool. This study is the first performing a systematic
comparison of methods, including an investigation of which are more suitable for clinical
use. This included the extraction of 43 features from the ECG, and the calculation of 21
different metrics. Finally, this study assessed the performance of those methods mostly
in an unsupervised manner.
5.2 Methods and materials
5.2.1 Study population
The PAF prediction challenge database (AFPDB) [90, 113] consists a pair of 30-minute
excerpts of two-channel 24h long-term ECG recordings from subjects falling into three
different categories: healthy controls ("Healthy"), PAF patients far away from the arrhyth-
mia onset (no episode 45 minutes before or after the record; "PAF far"), and PAF patients
just before the arrhythmia onset ("PAF close"). For the healthy controls, the pair of ECG
segments was chosen at random times in the 24 hour recording. The signals have a sam-
pling frequency of 128Hz and a 12-bit resolution. The database is divided into a learning
set and a testing set of equal size, and both contain approximately the same number of
healthy subjects and patients who will develop PAF. The training set contains 50 records
from healthy subjects, 25 from PAF far, and 25 from PAF close.
Given that the ECG recordings were not recorded with the special intention of study-
ing the P-wave, 39 recordings from the training set were removed from the analysis due
to the absence of discernible P-waves. This resulted in 61 records in the training set: 32
healthy, 14 PAF far, and 15 PAF close. Finally, for each subject, the channel in which
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the P-waves were most pronounced was chosen and used throughout the analysis. The
testing set was not used since no information is provided on which subjects belong into
which category in this set.
5.2.2 Signal preprocessing and delineation
The original ECG signals were preprocessed by applying a forward/backward filtering
strategy, an approach which has been demonstrated to preserve the P-wave fiducial points
[104]. This filter consisted of a 2858th-order bandpass filter with cut-off frequencies of
0.5 and 40Hz, and had the aim of removing baseline wander and high frequency noise.
5.2.2.1 R-peak detection
The delineation process started with R-peak detection using the widely used Pan, Hamil-
ton and Tompkins algorithm [100, 101]. Briefly, the ECG signal was differentiated,
squared, and a moving average filter was applied (Figure 5.1). Next, windows contain-
ing R-peaks (starting at QRSleft and ending at QRSright) were defined using a signal-
dependent threshold. Finally, the R-peak was identified as the maximum absolute value
of the ECG signal within those windows.
5.2.2.2 Q-wave detection
Q-wave detection and P-wave delineation were performed based on the phasor transform
(PT) [104]. The PT converted each instantaneous sample of the ECG signal (S[n]) into a
phasor of amplitude M[n] and phase φ[n], such that:
P T {S[n]} =M[n]ejϕ[n] (5.1)
where the magnitude M[n] and phase ϕ[n] of this phasor were computed as:
M[n] =
√
R2v + S[n]2 (5.2)
and
ϕ[n] = arctan
(
S[n]
Rv
)
(5.3)
In this way, by considering the instantaneous phase variation ϕ[n], the subtle alterations
provoked by the ECG waves in the recording were maximised, regardless of eventual low
amplitude, thus making their detection and delineation considerably easier (Figure 5.1).
The value of Rv determined the degree to which the ECG waves were enhanced by
the PT: the lower the value of Rv , the higher the differences among phase variations in
the complex plane [104]. Hence, Rv was changed according to the ECG wave aimed to be
detected or delineated, as described further below.
The detected R-peaks served as a reference for the identification of the Q-waves. To
do so, firstly, signal was extracted from an window beginning 50ms before QRSleft and
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ECG signal
Pan & Thompkins
Phasor Transform
Figure 5.1: Transformations of the electrocardiogram (ECG) signal (top) obtained using
the Pan & Thompkins algorithm [100, 101] (i.e. by differentiating, squaring, and apply-
ing a moving average filter; middle), and the phasor transform [104] (bottom). These
transformations were used to delineate the ECG fiducial points.
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ending at QRSright (of the corresponding R-peaks). Then, the absolute value of that
portion of signal was calculated, its median was removed, and the PT was applied with
Rv = 0.001. This approach was distinct from that originally described in the literature
[104], where the PT is applied directly to the absolute value of the entire ECG signal,
which causes ϕ[n] to be strongly influenced by noise. Next, a boundary point γQRS− was
defined as the closest point before the R-peak in which ϕ[n] was lower than 25% of the
maximum phase variation (pi/2).
Afterwards, another signal portion was extracted with a window starting 35ms before
γQRS− and ending at γQRS−. The absolute value of that segment was computed, its median
was removed, and the PT was applied with Rv = 0.005 in order to minimise the effect of
interfering noise. Finally, the Q-wave was detected on that signal. To do so, the lowest
local minimum in ϕ[n] was found (in the case that ϕ[n] had no minima, the lowest value
was picked instead). Next, points in the window were identified which were both earlier
than this minimum and had values of greater than 50% of the maximum value of ϕ[n]
within the window. If any points meeting these criteria were identified, then among the
phasors exceeding the threshold, the one with the highest magnitude M[n] was marked
as the Q-wave. Otherwise, the Q-wave was identified as the picked minimum.
5.2.2.3 P-wave detection and delineation
Two approaches were implemented for P-wave detection and delineation: the PT and a
wavelet-based algorithm [103]. By assessing their performance on the QT database [122],
we found that, while there was some improvement in performance using the wavedet
algorithm, both approaches gave satisfactory results. However, given that the perfor-
mance of the PT was much better in patients prone to AF, it was used during the analysis.
More details on the performance assessment of both P-wave delineators can be found in
Appendix A.
P-wave detection
In order to detect the P-wave, a seek window previous to the Q-wave was established.
The width of this window was normally one quarter of the last RR interval (i.e. the time
between the current R-peak and the previous one), but in cases where this interval was
greater than 1.5 times the mean RR (e.g., when one or more R-peaks were not detected),
the width was defined as half of the mean RR. This allowed to compensate for errors
in R-peak detection, averting for the detection of waves other than the P-wave. Next,
the median from that ECG segment was removed, and the PT was applied with Rv =
0.003. The maximum value of ϕ[n] within that window was located and if it was a
local maximum in M[n], that point was annotated as the P-wave peak (Figure 5.2). If
the maximum was not associated with a M[n] peak, the start or end of the window was
shortened by 15ms because part of the preceding T-wave or next Q-wave could have
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been included within the initial window. This process was repeated iteratively until the
detection of a P-wave peak occurred or the window length was null.
PT
S[n]
φ[n]
S[n]
φ[n] φ[n]
PT PT
1   P-wave detection 2   P-wave delineation
Figure 5.2: Representation of the P-wave detection and delineation process, using the
phasor transform (PT). An adaptive window relative to the R-peak was used to detect the
P-wave peak. Around this peak, two windows were established to delineate the P-wave
onset and offset.
Finally, in contrast to the original algorithm where P-waves with amplitudes of less
than 5% of the R-peak amplitude are discarded [104], all the detected P-waves were
included at this point. Then, we used the PQI algorithm (described in Chapter 4) to
exclude absent and low quality P-waves from the analysis. By excluding such P-waves,
we ensured that the analysis was performed using only reliable measurements.
P-wave delineation
The detected P-wave peaks served as reference for the delineation of the P-wave. The
onset and offset were thus individually searched. For the P-wave onset delineation, a
75ms window relative to the P-wave peak was established before that point. The median
of that window was removed, and the PT was computed with Rv = 0.005 (Figure 5.2).
Next, all the local minima were calculated. The closest minimum to the P-wave peak with
at least 90% the value of the lowest amplitude minimum was found. If that point indeed
existed and had an amplitude lower than 90% of the lowest value of the ϕ[n] within
that window, the P-wave onset was marked; otherwise, the process was repeated with
a wider window of 115ms, as the onset was probably not contained within that initial
window. This additional search procedure allowed for wider P-waves - an important
improvement to the original algorithm. If the P-wave onset was still not found within
that larger window, the two aforementioned search procedures were repeated with lower
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values fo Rv , until the location of the onset was found, or while Rv > 0. Naturally, the
P-wave offset delineation was based on the same process, with the difference that the
search windows were established after the P-wave peak.
The process for negative P-waves was similar, but used negative values for Rv . Given
that there were only 3 records with negative P-waves, this adaptation was performed
manually.
Out of the 61 records included in the analysis, 26.2% needed their P-wave detection
and delineation to be manually improved: 1.7% had the P-wave peak search window
extended, and 24.5% had the P-wave onset/offset search window extended or shortened.
Out of these records, 75.0% were from PAF patients.
5.2.3 Feature extraction
A selection of previously proposed ECG features were extracted in a beat-to-beat fashion
(Table 5.1). The majority of the features were related to the P-wave, and have been
previously used to predict AF. A time-series of feature measurements was extracted for
each feature and for each patient (one data point per beat). Below we describe the more
complex features.
5.2.3.1 Correlation coefficient index (CCI)
P-wave morphology variability was estimated by comparing each individual P-wave to a
template [27]. The lower the correlation between the template and a individual P-wave,
the more different they are, and vice-versa (Figure 5.3).
The methodology used to calculate this feature was adapted to be similar to that
for the PQI. Briefly, the process started by extracting the P-wave signal between the
corresponding onset and offset. Next, each P-wave was aligned and a template was created
as in the PQI tool (refer to Subsection 4.2.2 for further detail). Finally, the correlation was
computed using the cross-correlation with no temporal shift (i.e. point multiplication)
between each P-wave, Pi , and the template, T :
CCIi =
N∑
k=1
Pi[k]T [k] (5.4)
5.2.3.2 Warping index (WI)
Dynamic time warping (DTW) was used to compute P-wave variability [27]. According to
the DTW algorithm, the best alignment between two signals that are similar in shape but
out of phase can be obtained by compressing or extending the time axis in a non-linear
fashion. P-wave morphological variability was assessed by calculating the "amount" of
modification required to maximise similarity between P-waves (Figure 5.3).
Given two P-waves, X = {x1,x2, ...,xN } and Y = {y1, y2, ..., yM}, a matrix G(N ×M) con-
taining the distance between each point from X and each point from Y was built. Hence,
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Table 5.1: Selection of features extracted from the electrocardiogram signal.
Feature Description
Time features
Pdur/Pdur,RRnorm P-wave duration (either normalised with the current RR
interval or not) [24, 25, 106, 123]
Pinit. dur/Pfin. dur P-wave initial/final duration: from onset to peak/from
peak to offset, respectively [24, 25, 106]
PQon/ PQoff/
PQon.RRnorm/ PQoff.RRnorm
PQ interval measured from P-wave onset/offset, respec-
tively (either normalised with current RR or not) [24,
123]
PRon/ PRpeak/
PRoff/ PRon,RRnorm/
PRpeak,RRnorm/ PRoff,RRnorm
PR interval measured from P-wave onset/peak/offset,
respectively (either normalised with current RR or not)
[24, 25, 123]
RR Time interval between R-peaks
Morphology features
Pamp/ Pamp, Rnorm P-wave amplitude (either normalised with R-peak am-
plitude or not) [24, 26]
Poff amp P-wave offset amplitude [24]
Pmagn P-wave magnitude: max{P} −min{P} [106]
Passy P-wave assymetry: P init. dur/P fin. dur [25]
Pskew P-wave assymetry measured with skewness
Pmin.vel/Pmax.vel P-wave minimum/maximum velocity [26]
Pvel. disp. P-wave dispersion: Pmin.vel − Pmax.vel [26]
Pal P-wave arc-length [26]
Prms,norm P-wave root mean square (RMS), normalised with the
number of samples [26]
Parea/Parea,norm P-wave area (either normalised with Pal or not) [26]
Penergy/ Penergy,norm P-wave energy (either normalised with Pal or not) [26]
Penergy ratio P-wave energy ratio [26]
Pgauss. W/ Pgauss. C/
Pgauss. A/ Pgauss. error
P-wave Gaussian modelling parameters and error [105]
(see Subsection 5.2.3.3 for details)
Peucl. dist. Euclidean distance between subsequent P-waves [124]
(see Subsection 5.2.3.4 for details).
CCI Correlation coefficient index [27] (see Subsection
5.2.3.1 for details)
WIp, WIt Warping index [27] (see Subsection 5.2.3.2 for details)
PQlevel/ PQlevel,Rnorm/
PQlevel,Pnorm
PQ segment mean amplitude (either non-normalised or
normalised with R-peak or P-wave peak amplitude) [24]
Qlevel Q-wave amplitude [24]
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element g[i, j] represented the relative distance between the two P-wave points xi and yj .
The warping function (WF) was obtained, for a given cost function, by searching in matrix
G the minimum cost path leading from point g(N,M) to g(1,1) [125, 126]. Finally, the
warping index (WI) was the path length (expressed in number of samples), and was used
to estimate variability [27]. The higher the WI, the more different are the two P-waves,
and vice-versa.
The WI was extracted for every pair of consecutive P-waves (WIp) and, additionally,
between every P-wave and a P-wave template (created as in the CCI feature; WIt).
CCI = 3.5x10-2, WIt = 18 CCI = 3.5x10
-2, WIt = 19 CCI = 3.2x10
-2, WIt = 22 CCI = 2.6x10
-2, WIt = 27 CCI = 1.8x10
-2, WIt = 31
Figure 5.3: Examples displaying P-waves (solid line) and their template (dashed line), and
correspondent correlation coefficient index (CCI) and warping index (WIt). As indicated,
increasing differences in morphology between P-waves and their template are associated
with a decrease in CCI, and a increase in WIt.
5.2.3.3 P-wave Gaussian modelling (Pgauss.)
In order to quantify morphology changes, each individual P-wave was modelled by a
Gaussian function [105]. Hence, by comparing the Gaussian fitting parameters, we could
assess several morphology features.
P-waves were modelled with a Gaussian function of the form:
pˆ[n] = A.e−((n−C)/W )2 (5.5)
where the constants A, C, and W represented amplitude, peak time-position, and width,
respectively. Those parameters were computed by fitting the Gaussian function pˆ[n] to
the P-wave p[n] by a non-linear least-squares approach.
Considering a logarithmic transformation, the P-wave signal p[n] and its Gaussian
model pˆ[n] were related as:
ln(p[n]) = ln(pˆ[n])
= ln(A)−
(
n−C
W
)2
(5.6)
Defining the variables b = ln(p[n]), a2 = −1/W 2, a1 = 2C/W 2, and a0 = ln(A) − (C/W )2,
Equation 5.6 can be written as a second-order polynomial:
b = − 1
W 2
n2 +
2C
W 2
n+ ln(A)−
(
C
W
)2
(5.7)
= a2n
2 + a1n+ a0
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Considering discrete values of n, coefficients a2, a1, and a0 can be obtained by solving the
following system of linear equation:
b(n1) = a2n1
2 + a1n1 + a0
b(n2) = a2n2
2 + a1n2 + a0
...
b(nL) = a2nL
2 + a1nL + a0,
(5.8)
where ni is the ith time instant for which the P-wave is defined. This system can be
expressed in matrix notation as:
b = N · a (5.9)
where b =
[
b[n1],b[n2], ...,b[nL]
]T
, a = [a2, a1, a0]T , and
N =

n21 n1 1
n22 n2 1
...
...
...
n2L nL 1

(5.10)
By premultiplying Equation 5.9 by the matrix transpose NT , the vector a can be computed
as:
a = (NT .N)−1.NT .b (5.11)
Once a was calculated, containing the indices a2, a1, and a0, the constants A, C, and W
could be calculated as follows:
W =
√
− 1
a2
(5.12)
C =
a1W
2
2
(5.13)
A = e(a0+(C/W )
2) (5.14)
Finally, differences between each P-wave and its Gaussian model were quantified using
the normalised root mean square error (Figure ):
 =
√√∑L
k=1
∣∣∣pˆ[k]− p[k]∣∣∣2∑L
k=1 pˆ[k]
2
(5.15)
5.2.3.4 Euclidean distance between P-waves (Peucl. dist.)
The beat-to-beat euclidean distance between subsequent P-waves was used as an index of
P-wave stability [124]. The greater the distance between P-waves, the more different they
are, and vice-versa.
Firstly, the signal of each P-wave was extracted between the corresponding onset and
offset, and the time-position of their centroid was calculated. Next, the P-waves were
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ε = 0.15% ε = 0.48% ε = 6.19%ε = 3.75% ε = 7.24%
Figure 5.4: Examples displaying original P-waves (solid line) and their Gaussian mod-
elling (dashed line). As can be appreciated, increasing differences in morphology are
associated with increased root mean square error, . Adapted from Martinez et al. [105].
realigned with regard to their centroid (time-wise) and onset voltage (voltage-wise). The
delineated P-waves had varying durations. For the purposes of calculating the Euclidean
distance between P-waves we ensured that the first and second half of each P-wave had
durations equal to the longest durations across the pair of P-waves. This was achieved by
extracting longer periods of signal for the shorter P-waves in order to extract the desired
P-wave duration. Finally, the euclidean distance between the two resynchronised P-waves
was computed as follows:
P eucl. dist., i =
√∑N
k=1(Pi+1[k]− Pi[k])2√∑N
k=1(Pi+1[k])
2
, (5.16)
where Pi[k] was the kth sample of the ith P-wave.
5.2.4 Metric calculation
The metric calculation stage allowed, for each method, to summarise each feature time-
series as a single parameter. The obtained metrics were then used in the statistical analysis
and in the prediction of AF. Implemented methods included the simple mean and stan-
dard deviation (SD), and several variability methods (Table 5.2), which will be described
in depth below.
5.2.4.1 Linear variability time course
The time course of the features’ variability on the 30-minute recordings was studied
based on a linear regression method [25, 26, 105]. This method was used to understand
how the features’ variability progressed with time (Figure 5.5).
First, the time-series of a given P-wave feature was divided into segments of S samples.
Next, a variability series was obtained by computing the difference between the 10th and
90th percentiles of each segment of S samples. In this way, outliers due to artefacts could
be attenuated or rejected. An optimal value of S allowed slight variations in P-wave
dynamics to be tracked, while minimising the effect of noise.
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Table 5.2: Implemented methods, and corresponding computed metrics.
Method name Metrics Method explanation
Simple statis-
tical metrics
• Mean
• Standard deviation (SD)
Computes the mean value and the
amount of variation (SD) of a feature’s
time-series.
Linear variability • Slope of regression (α)
• Median variability (m)
Calculates the variability of a feature’s
time-series, and studies how that vari-
ability progresses with time (increases
[α > 0], decreases [α < 0] or maintains
[α = 0]).
Non-linear variability • Central tendency mea-
surement (CTM)
Computes the feature’s time-series
variability using difference plots. The
higher the CTM, the lower the vari-
ability, and vice-versa.
P-wave ampli-
tude dispersion
• Amplitude dispersion in-
dex (ADI)
Quantitative indicator of P-wave mor-
phology variability. The greater the
ADI, the greater the variability, and
vice-versa. Uses the P-waves’ signal.
Heart rate variability • RR, SDRR, SDSD,
RMSSD, NN20, pNN20,
NN50, pNN50
• TP, VLF, LF, HF, pHF,
pLF, LF/HF
Studies the variability of the RR se-
ries using metrics from time- and
frequency- domain. Gives indications
on the autonomic nervous system.
RR, mean RR; SDRR, standard deviation (SD) of RR; SDSD, SD of successive RR intervals; RMSSD, root mean square of differences
between successive RR intervals; NN20/ NN50, number of RR pairs differing by at least 20/50ms, respectively; pNN20/ pNN50,
percentage of NN20/ NN50, respectively; TP, total power; VLF, very low frequency power; LF, low frequency power; HF, high frequency
power; pHF/ pHF, percentage of HF/ LF, respectively; LF/HF, ratio of LF to HF.
Finally, the features’ variability trend was estimated by fitting a straight line to the
variability series:
yˆ = αx + β (5.17)
where x = {1,2, ...,N }, withN being the number of segments with S samples under analysis.
The slope α was computed so that it minimised the linear regression model’s squared
residuals, i.e.:
α =
∑N
i=1(x(i)− x¯)(y(i)− y¯)∑N
i=1(x(i)− x¯)2
(5.18)
where y¯ and x¯ were the mean values of y and x, respectively. The fitting slope α was
therefore indicative of the feature variability time course: a positive or negative slope
indicated increasing or decreasing variability, respectively, while a null slope indicated
constant variability over time.
Finally, in addition to studying the variability time course, we have quantified the
variability itself by taking the median value of the variability series (Figure 5.5).
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The aforementioned slope and median variability metrics were computed for several
values of S, which was varied from 10 to 40.
0 50 100 150 200 250
Number of S P-wave length intervals
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slope (α) = 0.19
median = 60
Figure 5.5: Two different metrics were extracted from the variability series: slope of linear
fitting (blue) and median (green).
5.2.4.2 Non-linear variability
Alterations of the P-wave features’ non-linear dynamics were quantified using the Cen-
tral Tendency Measurement (CTM), a method which makes use of a difference-plot to
compute variability [107, 127].
Given a feature time-series f and a lag d, the dth-order difference plot corresponded
to the plot (f [n+ d + 1]− f [n+ d]) vs. (f [n+ 1]− f [n]): a dispersion plot centred around
the origin (Figure 5.6). The CTM metric was computed as the proportion of points that
lied within a circular region centred on the origin with radius ρ. Thus, a low CTM value
reflected high variability, while a high CTM value reflected low variability.
From a mathematical point of view, given a feature time-series f with N data points,
the dth order difference plot contained N − d − 1 points. Hence, the dth-lagged CTM was
computed as:
CTM[d] =
∑N−d−1
i=1 δd[i]
N − d − 1 (5.19)
where
δd[i] =
1, if Dd[i] < ρ0, otherwise (5.20)
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with Dd[i] being the euclidean distance from the ith point from the dth-order difference
plot to the origin:
Dd[i] =
√
(f [i + d + 1]− f [i + d])2 + (f [i + 1]− f [i])2 (5.21)
Variability was studied by computing the CTM metric from lags d = 1,2, ...,10, and by
varying the selection radius ρ = 5.1,5.2, ...,10 multiples of the standard deviation of the
analysed data-series (f ). Given that no guidelines exist to optimise ρ, normalisation with
regard to the standard deviation provided translation and scale invariance [107].
-150 -100 -50 0 50 100 150
f [n+1] – f [n]
-150
-100
-50
0
50
100
150
f [
n+
2]
 –
 f 
[n
+1
]
CTM = 
2199
2199 + 69
Figure 5.6: The central tendency measurement metric was calculated as the proportion
of points that lied within a circular (green) region on the difference plot.
5.2.4.3 P-wave amplitude dispersion
The amplitude dispersion index (ADI) was used as a quantitative indicator of P-wave
morphology variability [27]. The greater the ADI, the greater the variability, and vice-
versa.
For each sample, the amplitude dispersion (AD) was calculated as the difference
between the maximum and minimum amplitude values across all the P-waves (Figure
5.7):
AD[n] =max{P [n]} −min{P [n]} (5.22)
where max{P [n]} and min{P [n]} corresponded to the maximum and minimum value of
the nth sample across all P-waves, respectively. Finally, the extracted index of P-wave
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variability (ADI) was the maximum value of AD divided by the maximum amplitude
value across all P-waves:
ADI =
max{AD}
max{P } (5.23)
Differently from the original study [27], where the ADI was calculated and averaged over
the 12 ECG leads, we calculated the metric for a single ECG channel.
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Figure 5.7: Calculation of the amplitude dispersion index (ADI) metric was performed in
two steps. Firstly, the AD signal was computed by subtracting the maximum value across
all P-waves (red) from the minimum values across all P-waves (blue). Finally, the ADI
was calculated by dividing the maximum value of the AD signal by the maximum value
across all P-waves.
5.2.4.4 Heart Rate Variability
Heart rate variability was studied in order to assess the role of the autonomic nervous
system in the initiation of PAF. In order to eliminate artefacts in the RR-series (e.g., due
to noise in the ECG signal, wrong R-peak detections, or atrial premature beats), a pre-
processing filter was applied. This filter eliminated unreasonable RR intervals which
differed by more than 20% from the mean of the current and previous RR interval, rr:
rri =
2(RRi −RRi−1)
RRi +RRi−1
(5.24)
Using the filtered RR series for the entire 30-minutes, several metrics from the time
domain were calculated:
1. Time-domain metrics:
a) RR: Mean of the RR series;
b) SDRR: Standard deviation of the RR series;
c) SDSD: Standard deviation of successive differences between adjacent RR inter-
vals;
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d) RMSSD: Root mean square of differences between adjacent RR intervals:
RMSSD =
√√(
1
N − 1
)N−1∑
i=1
(RRi+1 −RRi)2 (5.25)
e) NN20/pNN20: Number and percentage of RR pairs differing by at least 20ms;
f) NN50/pNN50: Number and percentage of RR pairs differing by at least 50ms.
In addition, after resampling of the given RR-series using spline interpolation, several
frequency-metrics were extracted using the fast Fourier transform (FFT):
2. Frequency domain metrics:
a) TP: Total power between the frequencies 0 and 0.4Hz;
b) VLF: Very low frequency power, calculated between the frequencies 0 and
0.04Hz;
c) LF: Low frequency power, between the frequencies 0.04 and 0.15Hz;
d) HF: High frequency power, between the frequencies 0.15 and 0.4Hz;
e) pHF: percentage of power on the high frequency band;
f) pLF: percentage of power on the low frequency band;
g) LF/HF: low frequency power to high frequency power ratio;
5.2.5 Statistical analysis
Two comparisons were made: healthy controls vs. PAF patients, and PAF far vs. PAF close.
Non-parametric Wilcoxon rank sum tests (Mann-Whitney U-test) were performed, and
metrics with a statistical significance of p < 0.01 were considered as significant. Finally, a
Holm-Sidak correction [128, 129] was performed at a significance level of 0.05. For the
methods where several configurations were tested (linear and non-linear variability), this
statistical correction was performed for the metrics within each variation (e.g., for all the
linear variability metrics using S = 10). The presented significance levels were selected
in order to minimise the probability of type I errors (false rejection of a null hypothesis).
The uncorrected p < 0.01 allowed to find trends, while the corrected p < 0.05 allowed to
find results with more concrete evidence of statistical significance (i.e., results even more
likely to be true positives), as is commonly done in neuroimaging research [130].
For the methods where several variations were tested, the optimal variation was cho-
sen as the one providing the highest number of metrics significant after correcting for
multiple comparisons at p < 0.05. In case of a tie, the optimal variation was the one
providing the highest number of significant metrics at uncorrected p < 0.01. Once the op-
timal variation (optimal S for the linear variability, and lag for the non-linear variability)
was chosen for each comparison, it was used in the remaining analysis.
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5.2.6 Performance assessment
The ability of each single statistically significant metric to discriminate between the differ-
ent groups was assessed using the area under the receiver-operator curve (AUC) statistic,
evaluated through comparisons of the predicted records’ label and the corresponding
true categories.
Finally, two different decision trees were assembled, one for each group comparison.
These models were built in order investigate the non-monotonic relationships among
single parameters, thus aiming to improve group classification. All the features which
presented statistically significant differences were considered as candidate features for
the classification trees. The stopping criterion used for the three growth was that each
node contained fewer than 5% of all the observations. Performance was assessed using
10-fold cross validation, and was evaluated using the accuracy, sensitivity, specificity,
positive predictive value (PPV), and negative predictive value (NPV) statistics.
5.3 Results
5.3.1 Simple statistical metrics
Table 5.3 shows the significant (uncorrected p < 0.01) results obtained when comparing
healthy controls to PAF patients using the simple mean and standard deviation metrics.
The mean values of PQon.RRnorm, PRon, PRon RRnorm, PRpeak, PRpeak.RRnorm, PRoff.RRnorm,
Pamp, and Pamp, Rnorm were found to be significantly greater in PAF patients than in
controls. The same was found for the standard deviation of PRoff, PRoff.RRnorm, and
PRon.RRnorm. No result was statistically significant after correcting for multiple com-
parisons. Furthermore, no significant results were found when comparing PAF far and
PAF close.
5.3.2 Linear Variability
The optimal number of samples (S) used to compute variability was optimized for each
of the subject comparisons: S = 35 for healthy vs. PAF patients, and S = 10 for PAF far vs.
PAF close.
PAF patients had significantly higher median variability than controls in Pamp, Rnorm
while, in opposition, healthy subjects had higher median variability in RR (Table 5.4).
PAF close was found to have increasing variability, while the reverse was found for PAF
far in Pdur, PQoff, PQoff RRnorm, PRoff, PRoff RRnorm, Pamp, Pal, Parea, CCI, WIt, and Peucl. dist.
(Figure 5.8). No results remained significant after correction for multiple comparisons.
5.3.3 Non-linear Variability
The 1st order (lag = 1) difference maps were used to compute the CTM metrics for both
subject comparisons. Table 5.5 shows the metrics reaching significance, accompanied
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Table 5.3: Significant results (uncorrected p < 0.01) obtained when testing the simple sta-
tistical metrics and the heart rate variability analysis. Results significant after correction
for multiple corrections (corrected p < 0.05) are shaded in grey. The median value (and
the first/ third quartiles) of each group are presented.
Healthy vs. PAF patients
Metrics Healthy PAF P-value AUC
PQon.RRnorm [a.u.] 0.172 (0.149 / 0.191) 0.209 (0.187 / 0.265) 4.9×10−4 0.76
PRon [ms] 209.175 (187.982 / 225.827) 226.356 (222.170 / 244.444) 9.5×10−3 0.69
PRon RRnorm [a.u.] 0.256 (0.227 / 0.283) 0.297 (0.280 / 0.368) 3.7×10−4 0.77
PRpeak [ms] 150.824 (131.058 / 164.620) 180.936 (167.000 / 188.701) 2.1×10−3 0.73
PRpeak.RRnorm [a.u.] 0.184 (0.151 / 0.202) 0.227 (0.197 / 0.275) 1.4×10−4 0.78
PRoff.RRnorm [a.u.] 0.114 (0.090 / 0.139) 0.146 (0.126 / 0.171) 1.9×10−3 0.73
Pamp [mV] 0.078 (0.033 / 0.159) 0.151 (0.094 / 0.201) 2.5×10−3 0.73
Pamp, Rnorm [a.u.] 0.045 (0.014 / 0.072) 0.085 (0.069 / 0.123) 1.1×10−3 0.74
SD(PRoff) [ms] 10.570 (7.627 / 13.151) 16.199 (8.690 / 18.541) 8.4×10−3 0.70
SD(PRoff.RRnorm) [a.u.] 0.018 (0.014 / 0.022) 0.025 (0.017 / 0.029) 4.0×10−3 0.72
SD(PRon.RRnorm) [a.u.] 0.027 (0.023 / 0.034) 0.021 (0.019 / 0.026) 6.5×10−3 0.70
SDRR [ms] 0.085 (0.049 / 0.123) 0.048 (0.025 / 0.060) 2.2×10−4 0.78
LF [ms2] 0.718 (0.600 / 1.247) 0.565 (0.527 / 0.682) 1.2×10−3 0.74
SD, standard deviation.
Table 5.4: Significant results (uncorrected p < 0.01) obtained when using the linear vari-
ability metrics. No results remained significant after correction for multiple comparisons.
The median value (and the first/ third quartiles) of each group are presented.
Healthy vs. PAF patients (S = 35)
Metrics Healthy PAF P-values AUC
m(RR) [ms] 99.6 (62.5 / 824.2) 46.9 (29.3 / 206.4) 3.3×10−3 0.72
m(Pamp, Rnorm) [a.u.] 2.9×10−2 (2.3×10−2 / 4.2×10−2) 4.2×10−2 (3.1×10−2 / 6.0×10−2) 4.8 ×10−3 0.71
PAF far vs. PAF close (S = 10)
Metrics PAF far PAF close P-values AUC
α(Pdur) [ms] -1.6×10−2 (-3.8×10−2 / -5.7×10−3) 9.3×10−3 (1.5×10−3 / 3.6×10−2) 9.4×10−3 0.79
α(PQoff) [ms] -2.2×10−2 (-3.7×10−2 / 6.4×10−3) 1.7×10−2 (3.7×10−3 / 6.6×10−2) 8.3×10−3 0.79
α(PQoff RRnorm) [a.u] -2.7×10−5 (-5.2×10−5 / -1.3×10−5) 1.8×10−5 (-1.5×10−6 / 7.0×10−5) 5.6×10−3 0.80
α(PRoff) [ms] -2.7×10−2 (-5.2×10−2 / -9.9×10−3) 1.4×10−2 (4.3×10−3 / 5.3×10−2) 4.9×10−3 0.81
α(PRoff RRnorm) [a.u] -3.7×10−5 (-5.9×10−5 / -4.4×10−6) 2.2×10−5 (7.4×10−6 / 6.0×10−5) 6.4×10−3 0.80
α(Pamp) [mV] -5.0×10−5 (-5.5×10−5 / 5.8×10−6) 8.1×10−5 (-2.2×10−5 / 1.8×10−4) 6.4×10−3 0.80
α(Pal) [µVs] -2.0×10−3 (-4.8×10−3 / -7.4×10−4) 1.2×10−3 (1.9×10−4 / 4.6×10−3) 9.4×10−3 0.79
α(Parea) [µVs] -1.8×10−4 (-8.8×10−4 / -4.6×10−5) 2.6×10−4 (6.8×10−5 / 5.2×10−4) 4.2×10−3 0.81
α(CCI) [a.u] -3.4×10−5 (-4.8×10−5 / -1.4×10−6) 2.1×10−5 (-2.1×10−6 / 5.6×10−5) 9.4×10−3 0.79
α(WIt) [samples] -3.5×10−3 (-9.1×10−3 / 4.0×10−4) 4.0×10−3 (6.5×10−4 / 6.1×10−3) 3.2×10−3 0.82
α(Peucl. dist) [a.u] -9.2×10−5 (-1.4×10−4 / -2.8×10−6) 8.4×10−5 (9.9×10−7 / 1.6×10−4) 3.2×10−3 0.82
m, mean variability; α, slope of regression.
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Figure 5.8: Illustrative example of P-wave euclidean distance variability time course
from a typical patient far away from the onset of paroxysmal atrial fibrillation (PAF; left)
and from a typical patient close to the arrhythmia onset (right). Patients close to the
onset of PAF had a significantly higher variability slope than patients far away from the
arrhythmia onset.
by the associated optimal radius, ρ. The CTM calculated over PQoff, PQon, PQon.RRnorm,
PRoff, PRoff.RRnorm, PRon.RRnorm, PRpeak RRnorm, Pamp, Pamp, Rnorm, Pgauss. A, Pmagn, Pmin.vel,
Parea,norm, and CCI was significantly higher in healthy individuals than in PAF. From
those, only PRon.RRnorm, Pamp, Pamp, Rnorm, Pmagn, Pmin.vel, and CCI remained significant
after correction for multiple corrections. In addition, the CTM calculated over Pgauss. A
was significantly higher in PAF far than in PAF close. Finally, no CTM metric was signifi-
cantly higher in PAF (vs. healthy) nor in PAF close (vs. PAF far).
5.3.4 P-wave amplitude dispersion
The ADI metric was not found to significantly differ between any of the groups.
5.3.5 Heart rate variability
Healthy subjects had significantly higher SDRR and LF than PAF patients (Table 5.3),
which was still significant after correction for multiple comparisons. No HRV metric was
significantly different between PAF far and PAF close.
5.3.6 Performance assessment
The classification ability of each individual significant metric, measured using the AUC,
is presented in Tables 5.3 to 5.5. Finally, the decision trees built using the statistically sig-
nificant metrics are shown in Figures 5.10 and 5.11, and their classification performance
is presented in Table 5.6. Both decision trees had 0.88 accuracy, 0.82 sensitivity, and 0.93
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Table 5.5: Significant results (uncorrected p < 0.01) obtained when testing the non-linear
variability results. The presented values of optimal ρ correspond to the number of multi-
ples of the standard deviation which minimised the p-value for the correspondent feature.
Results significant after correction for multiple corrections (corrected p < 0.05) are shaded
in grey. The median value (and the first/ third quartiles) of each group are presented (in
arbitrary units).
Healthy vs. PAF patients (lag = 1)
Features Optimal ρ Healthy PAF P-value AUC
PQoff 6.0 1.0000 (0.9998 / 1.0000) 0.9995 (0.9970 / 1.0000) 6.0×10−3 0.68
PQon 5.5 0.9966 (0.9933 / 0.9991) 0.9943 (0.9886 / 0.9962) 8.4×10−3 0.70
PQon.RRnorm 6.0 0.9995 (0.9980 / 1.0000) 0.9977 (0.9953 / 0.9987) 4.2×10−4 0.76
PRoff 10.5 1.0000 (1.0000 / 1.0000) 1.0000 (0.9988 / 1.0000) 8.7×10−3 0.62
PRoff.RRnorm 9.5 1.0000 (0.9994 / 1.0000) 0.9989 (0.9978 / 1.0000) 5.2×10−3 0.69
PRon.RRnorm 5.0 0.9977 (0.9930 / 0.9998) 0.9874 (0.9787 / 0.9937) 2.0×10−4 0.78
PRpeak RRnorm 6.5 1.0000 (0.9974 / 1.0000) 0.9932 (0.9893 / 0.9993) 4.1×10−4 0.75
Pdur. RRnorm 5.5 0.9985 (0.9957 / 1.0000) 0.9949 (0.9905 / 0.9978) 1.7×10−3 0.73
Pamp 5.0 0.9936 (0.9903 / 0.9991) 0.9852 (0.9803 / 0.9922) 6.7×10−5 0.80
Pamp, Rnorm 5.0 0.9934 (0.9902 / 0.9984) 0.9870 (0.9836 / 0.9910) 1.1×10−4 0.79
Pgauss. A 5.0 0.9969 (0.9927 / 0.9985) 0.9905 (0.9873 / 0.9966) 4.1×10−3 0.71
Pmagn 6.0 0.9993 (0.9955 / 1.0000) 0.9966 (0.9918 / 0.9985) 7.4×10−4 0.75
Pmin.vel 7.5 1.0000 (1.0000 / 1.0000) 0.9981 (0.9971 / 0.9996) 5.8×10−5 0.78
Parea,norm 5.0 0.9947 (0.9894 / 0.9992) 0.9898 (0.9860 / 0.9925) 2.9×10−3 0.72
CCI 5.0 0.9969 (0.9924 / 0.9995) 0.9893 (0.9843 / 0.9951) 6.4×10−4 0.75
PAF far vs. PAF close (lag = 1)
Metrics Optimal ρ PAF far PAF close P-value AUC
Pgauss. A 6.0 0.9985 (0.9971 / 0.9990) 0.9933 (0.9888 / 0.9968) 1.3×10−3 0.85
ρ, radius used to compute CTM.
specificity. These decision trees included variability metrics (regression slope and CTM)
applied to several P-wave time- and morphological features.
Table 5.6: Classification results obtained when comparing healthy subjects to patients
who developed paroxysmal atrial fibrillation (Healthy vs. PAF), and patients far and close
to the arrhythmia onset (PAF far vs. PAF close).
Metric Healthy vs. PAF PAF far vs. PAF close
Accuracy 0.88 0.88
Sensitivity 0.82 0.82
Specificity 0.93 0.93
PPV 0.94 0.93
NPV 0.83 0.85
PPV, positive predictive value; NPV, negative predictive value.
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Figure 5.9: Illustrative example of difference plots from a typical healthy subject (left)
and a patient who developed paroxysmal atrial fibrillation (PAF; right). Patients who
developed PAF had significantly higher non-linear variability (as indicated using the
central tendency measurement; CTM) than healthy subjects.
Healthy PAF Healthy
PAF
PAF Healthy
CTM(Pmin. vel.) < 0.9998
CTM(PQon RRnorm) < 0.9991   
CTM(PQoff) < 0.9985
α(RR) < 50.7813   
CTM(PQon) < 0.9949  
CTM(Pmin. vel.) >= 0.9998
CTM(PQon RRnorm) >= 0.9991
CTM(PQoff) >= 0.9985
α(RR) >= 50.7813
CTM(PQon) >= 0.9949  
Figure 5.10: Decision tree built to compare healthy subjects (Healthy) to patients which
developed paroxysmal atrial fibrillation (PAF).
5.4 Discussion
Prediction of PAF is a clinically important challenge, because the loss of sinus rhythm
may by prevented using prophylactic treatments. Maintenance of sinus rhythm can lead
to improved hemodynamics and decreased symptoms and complications. Furthermore,
by avoiding the arrhythmia onset, there is a decrease in atrial anatomic and electrical
remodelling that causes increased susceptibility in future episodes of PAF [131]. Hence,
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PAF far PAF close
PAF close PAF far
α(Parea) < 1.8x10
-5
α(PQoff) < 0.032
CTM(Pgauss. A) < 0.998 
α(Parea) >= 1.8x10
-5
 α(PQoff)  >= 0.032
CTM(Pgauss. A) >= 0.998
Figure 5.11: Decision tree built to distinguish between patients with paroxysmal atrial
fibrillation that are far (PAF far) and close (PAF close) to the arrhythmia onset.
in the present chapter we aimed to identify individuals at risk of developing PAF based
on their ECG, and to predict the imminent onset of AF in individuals known to be at risk,
following the 2001 CinC challenge.
Several ECG features and metrics have been previously proposed to predict AF. How-
ever, a determination of which AF prediction methodology, if any, is more suitable for
clinical use, has never been performed. Thus, in the present study we have implemented
and refined previously proposed ECG features and metrics, and have tested if their combi-
nation improves the prediction of PAF. Finally, we ensured that only high quality P-waves
were included in the analysis by using the novel automated PQI tool.
We have identified several P-wave and HRV metrics to be predictors of PAF. P-wave
variability was found to be the best predictor, as it gave the highest number of significant
metrics and had the best overall classification ability, measured using the AUC (Tables
5.4 and 5.5). Furthermore, the built decision trees mostly contained P-wave variability
metrics (Figures 5.10 and 5.11). Like previous studies, we have found PAF to be associated
with higher P-wave related variability [25–27, 105, 107–109, 124, 127]. In addition, that
variability was significantly higher just before the arrhythmia onset [25, 26, 105, 107–
109, 127]. Finally, the combination of variability metrics was able to identify subjects
at risk of PAF and to predict the imminent onset of PAF with high specificity (0.93) and
good sensitivity (0.82) and accuracy (0.88). These results are better than those from the
majority of other beat-to-beat analyses (where accuracy ranged from 0.70 to 1.00; Table
3.3).
Unexpectedly, we have found the linear variability to decrease with time in PAF pa-
tients far away from the arrhythmia onset (Table 5.4, Figure 5.8). This effect was found
across several P-wave time and morphology metrics. A possible explanation for this trend
of decreased variability might be related to the timing in which the ECG signals from
PAF far patients were selected. Even though the recordings were extracted at least 45
minutes after the previous PAF episode, it might be that the heart was still recovering
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from the big impact that AF causes, which could explain the decrease of variability with
time. However, this hypothesis cannot be confirmed due to the lack of clinical informa-
tion contained within the database, and due to the lack of research into P-wave variability
during the recovery from AF.
Furthermore, unexpectedly, we did not found significant differences between Healthy
and PAF patients when using linear variability regression. This was probably due to
the fact that the PAF group contained subjects both from PAF close (with increasing
variability, α > 0) and PAF far (with decreasing variability, α < 0), which, together, led
to no significant differences when compared with Healthy subjects, which we expected
to have constant variability (α = 0) [25]. Nonetheless, as expected, non-linear variability
was augmented (i.e. lower CTM) in PAF (vs. Healthy) and in PAF close (vs. PAF far).
Finally, it is important to remark that, from a relatively large selection of features
(Table 5.1), only a few were found to be significant. This might be due to the relatively
low sampling frequency (128Hz), which might have hindered some subtle P-wave modifi-
cations that have been quantified at large sampling frequencies (1000Hz) in all previous
studies. Hence, the P-wave features which we have found to be significant are probably
the ones which are more pronounced and could be quantified at the present sampling
frequency. Indeed, the lack of high resolution ECG devices has been identified as an
obstacle for the wide clinical application of those proposed methods [27]. Hence, in the
present study, we identified features which were capable of predicting AF in commonly
used, low resolution ECG devices.
5.4.1 P-wave time analysis
Out of all the features, P-wave duration is accepted as the most reliable marker for atrial
conduction characterization. However, even though P-waves with prolonged duration
have been extensively associated with AF [23], other studies have failed to demonstrate
any remarkable P-wave prolongation [132]. Taken together, these results suggest P-wave
prolongation to be only a marker of atrial conduction slowing, and not an unavoidable
requirement for AF development [105, 132]. Even though we did not found P-wave
duration to be significantly longer prior to PAF, we found prolonged PQ and PR intervals
in patients susceptible to PAF, suggesting decreased conduction velocity of atrial impulses
until ventricular depolarization in that group.
Atrial depolarization is reflected in the ECG of patients prone to AF as the result
of an interplay of two overlapping effects: 1) a decrease in conduction velocity of atrial
impulses, causing prolongation of P-wave duration; and 2) overlap between atrial depolar-
ization and possible premature atrial repolarization due to decreased refractory period,
shortening P-wave duration. Hence, given the heterogeneous combination of both these
effects on patients at risk of AF, greater variability in P-wave time intervals was expected
in those patients. Indeed, we found P-wave duration and PQ and PR intervals to be asso-
ciated with higher variability in PAF patients (vs. healthy subjects) and in PAF close (vs.
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PAF far). These results are in line with previous studies showing the (non-linear and the
slope of the linear) variability of several P-wave time features to be greater in patients
with PAF, and within those patients, to increase as the arrhythmia onset approximated
[25, 107].
5.4.2 P-wave morphology analysis
P-wave morphology reflects the atrial depolarization in a three-dimensional space. It is
the result of a complex interplay of several factors such as [132]: 1) the origin of the sinus
beat and right atrial depolarization; 2) left atrial depolarization; and 3) shape and size of
the atrial chambers, which affect both the time and course of the depolarization process.
Alterations in P-wave morphology can reflect disturbances in the atrial depolarization
wavefront [133], which are, for instance, correlated with the induction of PAF [132].
Hence, our results of higher P-wave morphology variability are in agreement with
the disturbed conduction observed in the atrial myocardium susceptible to AF [105].
Electrophysiological alterations within the atria, such as the slow propagation velocity
of atrial impulses, inhomogeneous atrial activation and shortening of atrial refractory
period, precede the onset of AF [24]. Moreover, structural abnormalities within the atrial
myocardium, such as fibrosis, together with site-specific conduction delays, account for a
nonuniform anisotropic propagation of sinus impulses. This inhomogeneous conduction
is thought to play a major role in the initiation of reentry, due to the increased likelihood
of unidirectional block of premature impulses [132]. Together, all these determinants
invariably alter the way through which the sinus impulse travels across the atria, resulting
in highly variable P-wave morphology [105].
Our results are in line with a large number of studies showing altered P-wave mor-
phology to be an indicator of AF. Those studies have identified patients with fractioned
conduction to be at risk of AF firstly by using signal-averaged P-waves [23], and later, like
us, on a beat-to-beat basis. Indeed, by looking at each individual P-wave, it was possible
to capture subtle changes in P-wave morphology. Firstly, the non-linear variability and
the regression of variability of several P-wave morphological features, in both time [26]
and frequency [108, 109] domains, were found to distinguish between healthy subjects,
PAF far, and PAF close. Secondly, the metrics ADI, mean CCI and WIp [27], and mean
and SD of P-wave euclidean distance [124] were found to be predictors of PAF. In the
present study, we have extended those features by calculating their variability which,
indeed, were found to be significant, and to be better predictors than the simple origi-
nal proposed metrics, which were not significant (e.g., the mean value of CCI was not
significant, but its variability was). Finally, the identification of a distinct secondary P-
wave morphology, together with the analysis of the symlet wavelet energy, enabled the
identification of PAF patients in a recent study [120].
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5.4.3 Heart rate variability
During normal sinus rhythm, the heart rate (HR) varies from beat to beat. HRV results
from the dynamic interplay between multiple physiologic mechanisms that regulate the
instantaneous HR. Since short-term HR regulation is predominantly governed by sym-
pathetic and parasympathetic neural activity, study of HR fluctuations provides a way
to observe the state and integrity of the autonomic nervous system [134]. Furthermore,
autonomic nervous system activation can induce significant and heterogeneous changes
of atrial electrophysiology and induce atrial tachyarrhythmias, such as AF [135]. Hence,
we have studied the HRV in order to assess the role of the autonomic nervous system in
PAF.
We found the SDRR to be decreased in PAF patients. This result, together with the de-
creased median variability of the RR series, indicate the impaired ability of that group to
adapt to changing circumstances [134], which may predispose to untoward cardiac events
[136]. Our results are in line with a previous finding of increased stability (decreased
complexity) in PAF patients, using approximate entropy and detrended fluctuation analy-
sis [136]. Furthermore, other studies have shown lower complexity in episodes preceding
PAF compared to distant ones using several entropy indices [137, 138] and difference
plots [138].
The control group also exhibited higher LF than PAF patients. This result is in op-
position to previous findings of increased LF in patients who developed postoperative
AF [139], and in PAF patients immediately before the arrhythmia (compared to distant
ones) [137]. The LF component is directly associated with both the sympathetic and vagal
activity, which, for instance, have been associated with atrial fibrillation [135, 140]. For
instance, studies have revealed an important role of the sympathetic nervous system and
its complex interaction with the vagal system in triggering AF [140]. Nonetheless, it
should be pointed that the entire autonomic nervous system plays a role in the induction
of AF. Finally, given that no clinical information was provided, we could not asses the
influence of extraneous factors on this effect of increased LF in healthy subjects.
5.4.4 Limitations and Future Work
Even though the freely available CinC 2001 database stimulated research on the predic-
tion of AF, it presents some disadvantages. Firstly, the ECG signals were not recorded
with the special intent of studying the P-waves, which led us to reduce the sample size,
and to analyse and compare P-wave metrics from different leads. Secondly, the effects
of confounding factors, such as age and gender, could not be controlled, given that clin-
ical data was not provided. Finally, signals were sampled at 128Hz, which might have
hindered an accurate P-wave characterization in both time and morphological domain.
Nonetheless, this sampling frequency is commonly used in hospital bedside monitors.
It is also important to note that some features, which were previously found to be
predictive of AF, were not implemented. For instance, the P-waves’ frequency [108, 109]
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and time-frequency [120] contents could not be used to study their morphology, given
that the sampling frequency with which the ECG signals were acquired was too low (a
minimum of 400Hz are required to capture the frequency content up to 200Hz which
was used in these studies, according to the Nyquist theorem). Furthermore, even though
the number of ectopic beats has shown to be predictive of PAF [94], that method is only
feasible just before the arrhythmia starts, which is too late for the application of an
efficient prophylactic medication [136, 141].
Furthermore, even though we have shown that the combination of several metrics
improved the prediction of PAF, little effort was placed on the optimization of a classi-
fication model. Thus, further research should focus on the construction of models for
optimizing the prediction of AF. In addition, even though we developed an algorithm to
predict PAF, it was not tested against any rhythms other than sinus rhythm.
Moreover, the P-wave delineation process was not completely automated, as we had
to manually adjust 26.2% of the records, specially so in patients susceptible to PAF, prob-
ably due to the higher P-wave morphological variability that might have affected the
delineator’s performance.
Finally, further prospective studies with a larger sample size and considering wider
time intervals before the onset of AF would be desirable in future research. In addition,
the progressive inclusion of other rhythms and types of arrhythmias would be useful for
the validation and improvement of predictive methodologies.
5.5 Final Remarks
This chapter has presented a study on the prediction of PAF. The aim of this study was to
identify subjects at risk of developing PAF, and to predict the imminent PAF onset in pa-
tients known to be at risk. We have implemented and improved a selection of previously
proposed methodologies and we carried out the analysis mostly in an unsupervised way,
using the P-wave Quality Index tool. We found P-wave time and morphological variability
to be the best predictors of PAF, and that the combination of several variability metrics
improved the prediction performance.
The tools used to carry this study are being made available as a Matlab® toolbox of
resources at http://github.com/diogotecelao/AFPrediction. The toolbox automatically
performs: ECG signal pre-processing, delineation, feature extraction, metric calculation,
and statistical analysis of significance.
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Prediction of Postoperative Atrial
Fibrillation
This chapter presents a study on the prediction of postoperative atrial fibrillation (POAF).
The aim of this study was to predict POAF in clinically relevant scenario. This included
predicting POAF with up to 48 hours of antecedence, without supervision, and in a
real world clinical dataset. This was performed by extracting a selection of features and
metrics from the electrocardiogram (ECG), and by limiting the analysis to high-quality
P-waves using the P-wave Quality index tool (presented in Chapter 4). The ability of the
extracted metrics to predict POAF was studied at the following timestamps prior to the
arrhythmia onset: 1h, 2h, 4h, 6h, 12h, 18h, 24h, 30h, 36h, 42h, and 48h. Finally, POAF
prediction was performed by combining several indices.
6.1 Introduction
Postoperative atrial fibrillation (POAF) is the most frequent complication of cardiac
surgery [9]. Similarly to other types of atrial fibrillation (AF), it affects patient well-
being by increasing the risk of stroke, hemodynamic compromise, and mortality [13, 14].
In addition, it increases the hospital length of stay, and incurs additional treatment costs
[9]. In the long term, patients with an episode of POAF have a twofold increase in cardio-
vascular mortality [12], and a substantial increase in the risk of future AF and ischemic
stroke, compared to patients who remained in sinus rhythm after surgery [13–15].
Prediction of POAF has been mostly studied using preoperative risk stratification
models, aiming to identify patients at risk of developing POAF after the surgery. Those
studies have used risk factors, preoperative ECG features, or a combination of the two
(Chapter 3). Even though those studies obtained promising results, they were not suffi-
ciently reliable and robust to be applied clinically. To this regard, the best study achieved
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an accuracy of 0.83.
Most recently, research has focused on beat-to-beat analyses of the ECG during contin-
uous monitoring, thus enabling real-time clinical prediction of AF. Overall, these studies
have identified variability in P-wave time- and morphology features to be a predictor of
paroxysmal AF (PAF). However, these methods have only been tested during the two
hours prior to PAF and have not been tested in a broader control group containing heart
rhythms other than the sinus rhythm.
In this chapter we have investigated the ability of the previously proposed methods
to predict POAF up to 48 hours before its onset using a real world clinical database.
The present study is the first testing the ability of variability methods to predict POAF,
and is the first studying the prediction of AF so long before from the arrhythmia onset.
Prediction of POAF was performed up to 48 hours before its onset using a combination
of several methods, and mostly without supervision.
6.2 Methods and materials
6.2.1 Study population
The MIMIC-III (Medical Information Mart for Intensive Care III) [142], a freely accessible
critical care database, was used. It contains clinical notes and physiological measurements
from intensive care unit (ICU) patients at Beth Israel Deaconess Medical Center between
2001 and 2012. The dataset is divided into two separate parts: one containing clinical
information (MIMIC-III clinical database; version 1.4), and the other containing matched
waveform signals (MIMIC-III waveform database matched subset; version 1.0) for a sub-
set of ICU stays. The clinical database includes information such as demographics, vital
sign measurements made at the bedside (approximately 1 data point per hour), labora-
tory test results, procedures, and medications. The waveform database almost always
includes one or more electrocardiogram (ECG) signals, and often included continuous
photoplethysmogram (PPG) signals and arterial blood pressure (ABP) waveforms.
6.2.1.1 Cohort selection
A POAF group containing 19 patients was selected using the following inclusion criteria:
1) AF was noted in the patients’ clinical notes; 2) the AF episode happened after cardiac
or thoracic surgery; 3) there were at least 48 hours of ECG recordings before the first AF
episode; and 4) the ECG signal exhibited P-waves during the period before the onset of
POAF. Having selected a group of eligible patients, we manually annotated the exact time
at which the first AF episode started, and extracted 48 hours of lead II ECG recordings
leading up to the onset of POAF. From those 48 hours, we extracted one-hour segments
starting at the following timestamps prior to the arrhythmia onset: 1h, 2h, 4h, 6h, 12h,
18h, 24h, 30h, 36h, 42h, and 48h (Figure 6.1). This resulted in 209 recordings.
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Figure 6.1: One-hour recordings were extracted at different timestamps relative to the
onset of atrial fibrillation.
The control group contained 63 subjects and was selected using the following inclu-
sion criteria: 1) had cardiac or thoracic surgery; 2) had no registered heart rhythm other
than sinus rhythm, sinus tachycardia or sinus bradycardia; and 3) had at least 48 hours
of ECG recordings with visible P-waves. The first 48 hours of available lead II ECG were
then used, and one-hour segments were extracted at the same timestamps, but using
the 48th hour of ECG recording as a reference (instead of the onset of POAF). Finally,
we excluded any one-hour recordings in which the median heart rate calculated over
1-minute segments was lower than 50 beats per minute (bpm) or higher than 110 bpm.
This resulted in 530 recordings.
Finally, we used the following criteria to decide whether to include the one-hour
recordings in the analysis: 1) at least 50% of the beats had P-waves of high-quality; 2)
P-wave peaks could be well identified; and 3) P-wave onset and offset could be well delin-
eated. While P-wave quality assessment was performed automatically, P-wave detection
and delineation performance was assessed visually at random signal portions.
6.2.2 Signal preprocessing and delineation
Signal preprocessing and delineation of ECG fiducial points was performed in a similar
manner to that described in Section 6.2, but with some differences. Firstly, baseline
wander and high-frequency noise were removed with a band-pass filter. Next, R-peaks
were detected using the Pan, Hamilton and Tompkins algorithm [100, 101], as in Section
5.2.2, with the exception that the algorithm was applied over 100s windows to reduce the
effect of high amplitude artefacts. This was followed by a signal quality verification stage
(see Section 6.2.2.1), which was added with the purpose of removing ECG beats which
were highly corrupted by artefacts. Using the high-quality beats, we then performed Q-
and P-wave delineation using the phasor transform, as described in Section 5.2.2. Finally,
we excluded noise-corrupted P-waves using the P-wave quality index (PQI) tool (see
Chapter 4), but applying the first decision stage over the entire one-hour recordings (i.e.
the P-wave template from the first PQI decision stage was created using all the available
P-waves). This further reduced the effect of any high amplitude noise that remained after
exclusion of data using the signal quality verification algorithm.
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6.2.2.1 ECG Signal Quality Index
Signal quality analysis was performed using a previously proposed template-matching
algorithm [114]. The signal quality index (SQI) algorithm consisted of two parts. Firstly,
the heart rate and the beat-to-beat intervals were derived from the R-peak detections.
These were compared to a series of thresholds to determine whether their values were
physiologically plausible. Secondly, a template beat was calculated as the average of each
individual beat in a 10s window. The Pearson correlation between each individual beat
and this template was calculated, and compared to an empirical threshold indicating the
minimum acceptable correlation (0.66). A window was labelled as low quality if it failed
any of these tests. The template-matching process is illustrated in Figure 6.2.
Figure 6.2: Template-matching for electrocardiogram (ECG) signal quality assessment.
ECG signals were segmented into windows, and the correlation between individual beats
(grey lines) in a window and the windows’ beat template (blue lines) was calculated. If
the correlation was bellow an empirically determined threshold then the segment was
labelled as of low-quality (right). Otherwise, the segment was labelled as of high-quality
(left). Adapted from Charlton et al. [119]
6.2.3 Feature extraction and metric calculation
The features presented in Section 5.2.3 were extracted from the ECG signal in a beat-to-
beat fashion (Table 5.1). Those features were then summarised as metrics, using the same
methods presented in Section 5.2.4. Briefly, several metrics were calculated, including the
mean and standard deviation of the feature time-series, and the more complex calculation
of linear and non-linear variability measurements. In addition, the heart rate variability
(HRV) was also studied by extracting several common time and frequency indices from
the RR series, as detailed in Section 5.2.4.
Linear variability was computed, firstly, by dividing a features’ time-series into seg-
ments of S samples. Then, the variability within each segment was computed as the
difference between the 10th and 90th percentiles. Finally, the variability time course was
estimated using the slope (α) of a fitted linear model. Hence, a positive slope indicated
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increasing variability, and vice-versa, while a null-slope indicated constant variability.
In addition, variability was also quantified by taking the median value of the variability
series. S was varied from 10 to 100.
Non-linear variability was quantified using the central tendency measurement (CTM).
Briefly, the CTM was based on the plots of the dth-order differences and was calculated
as the proportion of points that fall within a circle of radius ρ around the origin. Hence,
the higher the CTM, the lower the variability, and vice-versa. The lag/order was varied
from 1 to 10 and the radius was varied from 0.1 to 10 multiples of the standard deviation
of the analysed feature data-series.
6.2.4 Statistical analysis and performance assessment
We compared controls and POAF patients at each extracted timestamp (i.e. controls
vs. POAF patients at a given hour before the arrhythmia onset) using non-parametric
Wilcoxon rank sum tests (Mann-Whitney U -test). Results were considered as significant
if their p-value was smaller than 0.01. A Holm-Sidak correction was performed at a
significance level of 0.05.
The performance of each statistically significant metric (uncorrected p < 0.01) for
discriminating between groups was assessed using the area under the receiver operating
curve (AUC) statistic, evaluated through comparisons of the predicted labels with the
records’ true groups. Finally, prediction of POAF was performed using a decision tree
model. All the metrics that had presented statistically significant differences, indepen-
dently of the time-stamp in which they were significant, were considered as candidates to
be included in the model. The stopping criterion used for the three growth was that each
node contained fewer than 5% of all the observations. Performance was assessed using
10-fold cross validation, individually at each of the studied time-stamps. Given the im-
balance between the two classes, only the sensitivity and specificity statistics were used,
as they are independent of class distributions. During the analysis, POAF was considered
the positive class.
6.3 Results
6.3.1 Inclusion of data
Out of the total 739 recordings from POAF patients and controls, 77 were excluded from
the analysis. From the 77 recordings, 37.6% were (correctly) excluded due to excessive
noise and artefacts, 10.3% due to the fact that the PQI tool excluded too many P-waves
unnecessarily (P-wave template corrupted by noise), 42.8% because P-wave peak, onset or
offset delineation was overall faulty (due to the nature of the signal), and 0.1% due to the
absence of P-waves. The number of subjects which contributed data at each time-stamp
varied and are presented in Figure 6.3. Finally, from the records that were included in the
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Table 6.1: Clinical characteristics of the subjects that were included in the analysis.
POAF patients Controls Total POAF vs. Controls
Age 71.9± 9.2 58.8± 13.8 62.0± 14.0 Z=3.8, p = 1.7× 10−4
Gender
(Male/ Female)
11/ 8 34/ 25 45/ 33 χ2=4.2×10−4, p = 0.9
Surgery type
(Cardiac/ Thoracic)
19/ 0 19/ 40 38/ 40 χ2=26.4, p = 2.7× 10−7
analysis, we had to manually adjust the P-wave peak search window in 1.4% of records,
and the P-wave onset/offset search window in 3.3%.
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Figure 6.3: Number of records per time stamp used in the analysis for POAF patients
(left) and controls (right).
Patients who had POAF were significantly (p < 0.05) older, and had a higher propor-
tion of cardiac surgeries (Table 6.1).
6.3.2 Prediction of postoperative atrial fibrillation
6.3.2.1 Simple statistical metrics
Table 6.2 shows the significant results (uncorrected p < 0.01) obtained when comparing
controls and POAF patients at the several timestamps using the simple statistical metrics.
The mean and standard deviation of several time and morphological features was greater
in POAF patients than in controls. Only the standard deviation of PQon RRnorm was
significant when correcting for multiple comparisons (corrected p < 0.05).
6.3.2.2 Linear variability
Significant results obtained when testing the linear variability metrics are presented in Ta-
ble 6.3. Briefly, the variability in both time and morphological features were significantly
different between POAF and controls far away from the arrhythmia (at least 18 hours
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Table 6.2: Significant results (uncorrected p < 0.01) obtained when testing the simple sta-
tistical metrics. No results remained significant after correction for multiple comparisons.
The median value (and the first/ third quartiles) of each group are presented.
Metrics Controls POAF P-value AUC
1 hour before POAF
SD(PQon) [ms] 16.182 (14.550 / 18.468) 19.483 (16.121 / 23.838) 7.5×10−3 0.72
SD(PQon RRnorm) [a.u.] 0.025 (0.022 / 0.028) 0.032 (0.026 / 0.037) 4.8×10−3 0.74
SD(PRpeak RRnorm) [ms] 0.013 (0.011 / 0.018) 0.020 (0.014 / 0.027) 9.5×10−3 0.72
2 hours before POAF
SD(Pdur. RRnorm) [a.u.] 0.024 (0.021 / 0.029) 0.032 (0.026 / 0.035) 4.8×10−3 0.74
SD(PQon RRnorm) [a.u.] 0.023 (0.020 / 0.027 0.032 (0.024 / 0.036) 1.6×10−3 0.77
SD(PRon RRnorm) [a.u.] 0.020 (0.018 / 0.025) 0.029 (0.023 / 0.037) 1.9×10−3 0.77
SD(PRpeak RRnorm) [a.u.] 0.011 (0.009 / 0.017) 0.020 (0.014 / 0.025) 5.9×10−3 0.74
6 hours before POAF
SD(PQon) [ms] 16.392 (14.262 / 18.707) 18.756 (16.919 / 26.307) 5.8×10−3 0.73
SD(PQon RRnorm) [a.u.] 0.025 (0.020 / 0.029) 0.033 (0.027 / 0.038) 2.4×10−4 0.81
SD(PQoff RRnorm) [a.u.] 0.016 (0.012 / 0.020) 0.021 (0.015 / 0.029) 9.8×10−3 0.72
SD(PRpeak) [ms] 5.980 (4.436 / 7.571) 8.992 (6.061 / 13.023) 5.5×10−3 0.73
SD(PRpeak) [ms] 0.011 (0.008 / 0.014) 0.017 (0.011 / 0.026) 4.5×10−3 0.74
18 hours before POAF
Peucl. dist. [a.u.] 0.108 (0.088 / 0.140) 0.145 (0.137 / 0.173) 9.3×10−3 0.71
36 hours before POAF
Poff amp. [mV] -0.084 (-0.108 / -0.068) -0.056 (-0.083 / -0.046) 7.4×10−3 0.72
PQlevel [mV] -0.079 (-0.099 / -0.063) -0.056 (-0.071 / -0.044) 4.3×10−3 0.74
Qon amp. [mV] -0.072 (-0.094 / -0.057) -0.048 (-0.063 / -0.037) 6.4×10−3 0.72
SD(Pamp.) [mV] 0.017 (0.011 / 0.029) 0.026 (0.020 / 0.046) 9.6×10−3 0.71
42 hours before POAF
SD(PRoff RRnorm) [a.u.] 0.013 (0.010 / 0.017) 0.018 (0.015 / 0.020) 7.3×10−3 0.74
SD(PQoff RRnorm) [a.u.] 0.015 (0.011 / 0.019) 0.019 (0.016 / 0.024) 8.2×10−3 0.73
48 hours before POAF
Peucl. dist. [a.u.] 0.098 (0.085 / 0.014) 0.147 (0.125 / 0.180) 8.3×10−3 0.74
SD, standard deviation.
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away), while only variability in P-wave time features were significant as the arrhythmia
onset got closer. The POAF group had higher median variability for all the presented
timestamps, and showed increasing variability (slope, α) in all timestamps except 18
hours before the arrhythmia onset. In contrast, controls presented decreasing variability
in the majority of variability regression slope results. The PQ interval (duration and
level) was the only feature which had metrics significant after correction for multiple
comparisons at 6 and 48 hours before the arrhythmia onset.
6.3.2.3 Non-linear variability
Non-linear CTM was found to significantly differ between POAF patients and controls
in all the tested timestamps (Table 6.4). Controls were associated with higher CTM
in the great majority of features and timestamps. However, CTM applied over the fea-
tures Pvel. disp., Pfin. dur, Pmagn., PQlevel, PQlevel Pnorm and Poff amp. was sometimes higher in
POAF patients. Finally, several P-wave time- and morphological metrics were significant
after correction for multiple comparisons 1, 12, 18, 42 and 48 hours before the arrhythmia
onset, all of them showing higher CTM in controls.
6.3.2.4 Heart rate variability
Several HRV metrics were significantly different between POAF patients and controls
either close (up to 2 hours) or far (at least 42 hours) from the arrhythmia onset (Table
6.5). All the presented time domain metrics were higher in POAF, whilst all the frequency
domain metrics, with the exception of pHF, were higher in controls. Only pLF, pHF, and
the LF/HF ratio were significant after correction for multiple corrections during the last
hour before AF onset.
6.3.2.5 Prediction performance
A decision tree was built (Figure 6.4) using the significant metrics listed above, and
was tested at each time-stamp (Figure 6.5 and Table 6.6). Its sensitivity increased as
the arrhythmia got closer, while its specificity was approximately constant. POAF was
predicted 48 hours before the arrhythmia onset with a sensitivity of 0.74 and a specificity
of 0.70. The decision tree used metrics derived from mean feature calculations and non-
linear variability.
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Table 6.3: Significant results (uncorrected p < 0.01) obtained when using the linear vari-
ability metrics. Results significant after correction for multiple corrections (corrected
p < 0.05) are shaded in grey. The median value (and the first/ third quartiles) of each
group are presented.
Metrics Controls POAF P-value AUC
1 hour before POAF (S = 5)
m(PQon RRnorm) [a.u.] 4.8×10−2 (4.0×10−2 / 5.7×10−2) 5.8×10−2 (5.0×10−2 / 7.6×10−2) 4.1×10−3 0.74
m(PRpeak RRnorm) [a.u.] 1.5×10−2 (1.2×10−2 / 2.2×10−2) 2.2×10−2 (2.0×10−2 / 4.0×10−2) 3.9×10−3 0.74
2 hours before POAF (S = 10)
m(Pdur. RRnorm) [a.u.] 5.5×10−2 (4.6×10−2 / 6.5×10−2) 7.2×10−2 (5.8×10−2 / 8.1×10−2) 2.9×10−3 0.75
m(PQon RRnorm) [a.u.] 5.1×10−2 (4.3×10−2 / 6.1×10−2) 7.6×10−2 (5.7×10−2 / 8.4×10−2) 1.1×10−3 0.78
m(PRon RRnorm) [a.u.] 4.0×10−2 (3.6×10−2 / 5.1×10−2) 6.5×10−2 (4.8×10−2 / 7.3×10−2) 4.1×10−3 0.75
m(PRpeak RRnorm) [a.u.] 1.7×10−2 (1.3×10−2 / 3.0×10−2) 3.5×10−2 (2.2×10−2 / 4.6×10−2) 3.9×10−3 0.75
4 hours before POAF (S = 10)
m(PRpeak RRnorm) [a.u.] 1.7×10−2 (1.3×10−2 / 2.4×10−2) 2.8×10−2 (1.9×10−2 / 4.1×10−2) 8.2×10−3 0.73
6 hours before POAF (S = 10)
m(Pfin. dur.) [ms] 24.0 (16.0 / 30.0) 28.0 (24.0 / 37.0) 5.7×10−3 0.73
m(Pdur. RRnorm) [a.u.] 5.9×10−2 (5.3×10−2 / 6.3×10−2) 7.1×10−2 (6.1×10−2 / 9.2×10−2) 2.2×10−3 0.76
m(PQon) [ms] 38.0 (32.0 / 44.0) 44.0 (36.0 / 58.0) 5.4×10−3 0.73
m(PQon RRnorm) [a.u.] 5.6×10−2 (4.4×10−2 / 6.2×10−2) 7.9×10−2 (6.0×10−2 / 9.0×10−2) 2.9×10−4 0.80
m(PRpeak) [ms] 8.0 (8.0 / 12.0) 16.0 (11.0 / 21.0) 1.6×10−3 0.75
m(PRon RRnorm) [a.u.] 4.8×10−2 (3.7×10−2 / 5.4×10−2) 6.9×10−2 (4.8×10−2 / 8.7×10−2) 5.3×10−3 0.73
m(PRpeak RRnorm) [a.u.] 1.5×10−2 (1.3×10−2 / 2.5×10−2) 3.3×10−2 (1.9×10−2 / 5.4×10−2) 4.5×10−3 0.74
12 hours before POAF (S = 5)
α(Qon amp.) [mV] -2.0×10−6 (-6.1×10−6 / -3.0×10−6) 6.8×10−6 (-1.1×10−6 / 1.1×10−5) 5.2×10−3 0.72
18 hours before POAF (S = 10)
α(PQon) [ms] 9.9×10−4 (-8.9×10−3 / 6.9×10−3) -9.5×10−3 (-2.4×10−2 / -2.0×10−3) 1.4×10−3 0.76
α(PQlevel, Pnorm) [mV] 2.5×10−4 (-7.2×10−5 / 1.5×10−3) -4.1×10−4 (-1.1×10−2 / 8.1×10−5) 1.3×10−3 0.78
α(PRon) [ms] -1.7×10−4 (-8.5×10−3 / 7.0×10−3) -7.1×10−3 (-2.8×10−2 / -1.7×10−3) 4.8×10−3 0.73
α(PRpeak) [ms] 2.5×10−4 (-3.5×10−3 / 4.4×10−3) -5.5×10−3 (-1.5×10−2 / -1.7×10−4) 8.1×10−3 0.71
36 hours before POAF (S = 30)
α(Pmin. vel.) [mV] -7.7×10−7 (-5.7×10−6 / 9.5×10−6) 1.9×10−5 (7.9×10−7 / 4.3×10−5) 7.7×10−3 0.72
α(Pvel. disp.) [mV] -1.1×10−6 (-1.1×10−5 / 1.6×10−5) 2.7×10−5 (2.4×10−6 / 6.2×10−5) 9.2×10−3 0.71
α(Penergy) [µV 2] -7.1×10−10 (-6.3×10−9 / 7.4×10−9) 1.1×10−8 (3.0×10−9 / 2.3×10−8) 3.4×10−3 0.74
α(Penergy norm.) [V/s] -1.1×10−10 (-6.9×10−10 / 4.7×10−10) 1.1×10−9 (5.1×10−10 / 1.8×10−9) 1.6×10−3 0.76
α(Pgauss. error) [a.u.] -5.1×10−8 (-3.8×10−6 / 2.4×10−6) 4.5×10−6 (-7.1×10−8 / 7.9×10−6) 4.9×10−3 0.73
m(Pfin. dur.) [ms] 24.0 (16.0 / 28.0) 32.0 (24.0 / 37.0) 6.7×10−3 0.72
42 hours before POAF (S = 5)
m(Pfin. dur.) [ms] 16.0 (16.0 / 24.0) 24.0 (24.0 / 32.0) 8.8×10−3 0.72
m(PQoff) [ms] 24.0 (16.0 / 24.0) 24.0 (24.0 / 32.0) 1.0×10−2 0.72
m(PQon RRnorm) [a.u.] 4.1×10−2 (3.6×10−2 / 5.4×10−2) 5.6×10−2 (4.4×10−2 / 6.9×10−2) 6.9×10−3 0.74
m(PQoff RRnorm) [a.u.] 3.1×10−2 (2.0×10−2 / 4.1×10−2) 4.2×10−2 (3.3×10−2 / 5.2×10−2) 4.8×10−3 0.75
m(PRoff RRnorm) [a.u.] 2.4×10−2 (1.4×10−2 / 3.5×10−2) 3.5×10−2 (3.0×10−2 / 4.3×10−2) 7.7×10−3 0.73
48 hours before POAF (S = 10)
α(Pmagn.) [mV] -1.4×10−5 (-3.4×10−5 / -8.1×10−7) 6.7×10−6 (-5.2×10−6 / 1.6×10−5) 2.1×10−3 0.78
α(Prms norm.) [mV] -6.3×10−7 (-1.5×10−6 / -4.1×10−9) 2.7×10−7 (7.8×10−8 / 6.4×10−7) 9.3×10−3 0.73
α(Penergy) [µV 2] -4.7×10−9 (-1.8×10−8 / 1.3×10−9) 2.0×10−9 (1.5×10−10 / 9.2×10−9) 7.0×10−3 0.74
α(Penergy norm.) [V/s] -4.1×10−10 (-1.2×10−9 / 4.1×10−11) 2.1×10−10 (9.6×10−12 / 1.6×10−9) 3.9×10−3 0.76
α(PQlevel, Pnorm) [mV] -3.7×10−3 (-7.0×10−2 / -6.6×10−4) 3.0×10−5 (-2.1×10−4 / 1.8×10−3) 7.4×10−4 0.86
m(Peucl. dist.) [a.u.] 9.3×10−2 (7.3×10−2 / 1.2×10−1) 1.4×10−1 (9.6×10−2 / 1.9×10−1) 6.6×10−3 0.74
m, mean variability; α, slope of regression.
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Table 6.4: Significant results (uncorrected p < 0.01) obtained when testing the non-linear
variability results. The presented values of optimal ρ correspond to the number of multi-
ples of the standard deviation which minimised the p-value for the correspondent feature.
Results significant after correction for multiple corrections (corrected p < 0.05) are shaded
in grey. The median value (and the first/ third quartiles) of each group are presented (in
arbitrary units).
Metrics ρ Controls POAF P-values AUC
1 hour before POAF (lag= 5)
PQoff RRnorm 3.0 0.8944 (0.8751 / 0.9085) 0.9089 (0.8996 / 0.9367) 2.7×10−3 0.75
PRoff RRnorm 8.0 1.0000 (0.9994 / 1.0000) 0.9994 (0.9979 / 1.0000) 6.0×10−3 0.71
PRon RRnorm 4.0 0.9863 (0.9791 / 0.9931) 0.9741 (0.9554 / 0.9814) 3.1×10−4 0.80
PRpeak RRnorm 3.5 0.9849 (0.9677 / 0.9942) 0.9529 (0.9303 / 0.9735) 5.4×10−4 0.79
Parea 13.0 1.0000 (1.0000 / 1.0000) 1.0000 (0.9999 / 1.0000) 1.2×10−3 0.62
Pdur. RRnorm 4.0 0.9822 (0.9758 / 0.9884) 0.9714 (0.9637 / 0.9767) 3.3×10−4 0.80
Peucl. dist. 4.0 0.9906 (0.9822 / 0.9930) 0.9754 (0.9658 / 0.9834) 3.1×10−5 0.85
Pgauss. A 6.0 0.9981 (0.9958 / 0.9990) 0.9947 (0.9907 / 0.9977) 3.9×10−3 0.74
Pmagn. 4.0 0.9826 (0.9770 / 0.9896) 0.9721 (0.9564 / 0.9816) 9.2×10−4 0.78
Parea norm. 4.0 0.9776 (0.9687 / 0.9843) 0.9647 (0.9560 / 0.9724) 4.8×10−4 0.79
Prms norm. 5.0 0.9912 (0.9855 / 0.9935) 0.9842 (0.9787 / 0.9896) 5.0×10−3 0.73
Pvel. disp. 4.0 0.9821 (0.9781 / 0.9870) 0.9764 (0.9726 / 0.9816) 3.5×10−3 0.74
CCI 10.5 1.0000 (1.0000 / 1.0000) 1.0000 (0.9993 / 1.0000) 3.5×10−3 0.74
2 hours before POAF (lag= 8)
PQoff 8.5 1.0000 (1.0000 / 1.0000) 1.0000 (0.9987 / 1.0000) 2.8×10−3 0.67
PRon 11.0 1.0000 (1.0000 / 1.0000) 1.0000 (0.9992 / 1.0000) 5.2×10−3 0.65
PRpeak 14.0 1.0000 (1.0000 / 1.0000) 1.0000 (0.9991 / 1.0000) 5.9×10−3 0.67
PQoff RRnorm 9.5 1.0000 (1.0000 / 1.0000) 1.0000 (0.9991 / 1.0000) 6.7×10−3 0.65
Peucl. dist. 4.5 0.9952 (0.9892 / 0.9968) 0.9884 (0.9756 / 0.9942) 2.8×10−3 0.76
Pgauss. C 14.5 1.0000 (0.9992 / 1.0000) 0.9991 (0.9986 / 0.9997) 7.1×10−3 0.71
Parea norm. 3.5 0.9593 (0.9466 / 0.9684) 0.9372 (0.9327 / 0.9548) 5.3×10−3 0.74
Pfin. dur. 6.0 0.9994 (0.9981 / 1.0000) 1.0000 (0.9998 / 1.0000) 2.7×10−3 0.75
4 hours before POAF (lag= 6)
Pdur RRnorm 6.0 0.9995 (0.9988 / 1.0000) 0.9982 (0.9957 / 0.9995) 4.6×10−3 0.75
PRon RRnorm 4.5 0.9928 (0.9882 / 0.9966) 0.9856 (0.9667 / 0.9913) 4.4×10−3 0.75
Parea 13.0 1.0000 (1.0000 / 1.0000) 1.0000 (0.9995 / 1.0000) 1.5×10−3 0.65
6 hours before POAF (lag= 6)
Penergy 11.5 0.9991 (0.9981 / 0.9997) 0.9980 (0.9961 / 0.9987) 8.3×10−3 0.72
Peucl. dist. 4.5 0.9941 (0.9895 / 0.9968) 0.9911 (0.9816 / 0.9922) 4.8×10−3 0.74
Pfin. dur. 6.0 0.9993 (0.9976 / 1.0000) 1.0000 (0.9994 / 1.0000) 5.9×10−3 0.72
12 hours before POAF (lag= 4)
PQoff 13.0 1.0000 (1.0000 / 1.0000) 1.0000 (0.9990 / 1.0000) 5.2×10−4 0.65
PQoff RRnorm 9.5 1.0000 (1.0000 / 1.0000) 1.0000 (0.9991 / 1.0000) 2.2×10−4 0.64
PQon 7.5 1.0000 (1.0000 / 1.0000) 0.9998 (0.9990 / 1.0000) 7.6×10−4 0.71
PQon RRnorm 8.0 1.0000 (1.0000 / 1.0000) 0.9997 (0.9985 / 1.0000) 6.1×10−4 0.72
Continued on next page
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Table 6.4 – continued from previous page
Metrics ρ Controls POAF P-values AUC
PQlevel 11.0 0.9996 (0.9990 / 1.0000) 1.0000 (1.0000 / 1.0000) 6.4×10−3 0.70
PRoff 16.0 1.0000 (1.0000 / 1.0000) 1.0000 (0.9994 / 1.0000) 2.5×10−3 0.62
PRoff RRnorm 11.0 1.0000 (1.0000 / 1.0000) 1.0000 (0.9993 / 1.0000) 7.0×10−3 0.63
PRon 8.0 1.0000 (1.0000 / 1.0000) 0.9995 (0.9986 / 1.0000) 5.6×10−5 0.75
PRon RRnorm 7.5 1.0000 (0.9991 / 1.0000) 0.9981 (0.9971 / 0.9998) 1.4×10−3 0.74
PRpeak 13.0 1.0000 (1.0000 / 1.0000) 1.0000 (0.9987 / 1.0000) 2.4×10−3 0.66
PRpeak RRnorm 22.0 1.0000 (1.0000 / 1.0000) 1.0000 (1.0000 / 1.0000) 7.2×10−3 0.58
Pal 7.0 1.0000 (1.0000 / 1.0000) 0.9998 (0.9997 / 1.0000) 6.2×10−4 0.70
Pdur. 7.0 1.0000 (1.0000 / 1.0000) 0.9998 (0.9997 / 1.0000) 6.2×10−4 0.70
Peucl. dist. 5.0 0.9974 (0.9937 / 0.9990) 0.9938 (0.9902 / 0.9953) 3.4×10−4 0.79
Pmagn. 10.0 0.9996 (0.9989 / 1.0000) 1.0000 (1.0000 / 1.0000) 3.2×10−3 0.72
Pvel. disp. 10.5 1.0000 (0.9993 / 1.0000) 1.0000 (1.0000 / 1.0000) 8.1×10−3 0.67
18 hours before POAF (lag= 9)
PQoff 9.5 1.0000 (1.0000 / 1.0000) 1.0000 (0.9988 / 1.0000) 6.5×10−3 0.63
Pal 1.0 0.2750 (0.2431 / 0.3175) 0.2420 (0.2335 / 0.2543) 2.6×10−3 0.74
Pdur. 1.0 0.2750 (0.2431 / 0.3175) 0.2421 (0.2335 / 0.2543) 2.6×10−3 0.74
Pdur. RRnorm 1.0 0.2907 (0.2503 / 0.3414) 0.2464 (0.2320 / 0.2735) 9.3×10−3 0.71
Peucl. dist. 4.0 0.9901 (0.9862 / 0.9931) 0.9827 (0.9633 / 0.9870) 1.2×10−3 0.76
Pini. dur. 2.0 0.6733 (0.6358 / 0.7047) 0.6468 (0.6180 / 0.6552) 8.5×10−3 0.71
24 hours before POAF (lag= 6)
Pal 8.0 1.0000 (1.0000 / 1.0000) 1.0000 (1.0000 / 1.0000) 4.9×10−3 0.59
Pdur. 8.0 1.0000 (1.0000 / 1.0000) 1.0000 (1.0000 / 1.0000) 4.9×10−3 0.59
Pmagn. 3.0 0.9461 (0.9349 / 0.9627) 0.9270 (0.9185 / 0.9405) 7.8×10−3 0.72
Pmax. vel. 3.5 0.9629 (0.9585 / 0.9706) 0.9576 (0.9467 / 0.9605) 3.9×10−3 0.74
Pmin. vel. 3.5 0.9625 (0.9561 / 0.9697) 0.9548 (0.9508 / 0.9633) 7.1×10−3 0.72
30 hours before POAF (lag= 7)
Parea 12.5 1.0000 (1.0000 / 1.0000) 1.0000 (1.0000 / 1.0000) 8.3×10−3 0.58
WIt 9.0 1.0000 (1.0000 / 1.0000) 1.0000 (1.0000 / 1.0000) 2.1×10−3 0.61
36 hours before POAF (lag= 3)
PQlevel 6.5 0.9972 (0.9952 / 0.9993) 0.9936 (0.9907 / 0.9966) 2.1×10−3 0.75
PQlevel Rnorm 6.5 0.9972 (0.9951 / 0.9989) 0.9950 (0.9911 / 0.9974) 9.5×10−3 0.71
Parea 5.5 0.9980 (0.9957 / 0.9993) 0.9945 (0.9908 / 0.9983) 9.2×10−3 0.71
Parea norm. 4.5 0.9886 (0.9833 / 0.9938) 0.9806 (0.9763 / 0.9886) 7.7×10−3 0.72
42 hours before POAF (lag= 1)
PQon 3.5 0.9387 (0.9278 / 0.9454) 0.9459 (0.9429 / 0.9520) 9.6×10−3 0.73
Penergy norm. 12.5 0.9993 (0.9986 / 0.9998) 0.9982 (0.9973 / 0.9987) 1.1×10−3 0.79
Pfin. dur. 3.5 0.9402 (0.9251 / 0.9537) 0.9571 (0.9470 / 0.9654) 4.6×10−3 0.75
WIt 8.0 1.0000 (1.0000 / 1.0000) 0.9998 (0.9997 / 1.0000) 9.7×10−3 0.68
48 hours before POAF (lag= 7)
PQlevel Pnorm 17.5 0.9982 (0.9975 / 0.9989) 0.9993 (0.9989 / 1.0000) 3.9×10−3 0.76
Parea 3.0 0.9181 (0.9010 / 0.9338) 0.8926 (0.8859 / 0.9262) 9.3×10−3 0.73
Pgauss. W 20.0 1.0000 (1.0000 / 1.0000) 1.0000 (0.9989 / 1.0000) 9.9×10−3 0.66
Continued on next page
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Table 6.4 – continued from previous page
Metrics ρ Controls POAF P-values AUC
Pmagn. 2.5 0.9210 (0.8766 / 0.9576) 0.8810 (0.8358 / 0.9132) 7.4×10−3 0.74
Parea norm. 2.0 0.8111 (0.7547 / 0.8485) 0.7089 (0.6585 / 0.7424) 1.5×10−4 0.84
Prms norm. 2.0 0.7889 (0.7472 / 0.8466) 0.6877 (0.6503 / 0.7236) 1.2×10−3 0.79
Poff amp. 8.0 0.9971 (0.9952 / 0.9986) 0.9992 (0.9980 / 1.0000) 2.3×10−3 0.77
Pfin. dur. 5.5 0.9988 (0.9962 / 0.9995) 0.9997 (0.9993 / 1.0000) 9.3×10−3 0.73
WIt 2.5 0.8301 (0.8163 / 0.8425) 0.8083 (0.8008 / 0.8246) 3.7×10−3 0.76
Table 6.5: Significant results (uncorrected p < 0.01) obtained when performing the heart
rate variability analysis. Results significant after correction for multiple corrections (cor-
rected p < 0.05) are shaded in grey. The median value (and the first/ third quartiles) of
each group are presented.
Metrics Controls POAF P-value AUC
1 hour before POAF
SDSD [ms] 0.016 (0.011 / 0.026) 0.036 (0.021 / 0.052) 7.9×10−3 0.72
RMSSD [ms] 0.016 (0.011 / 0.026) 0.036 (0.021 / 0.052) 7.9×10−3 0.72
pLF [%] 52.156 (48.477 / 55.595) 46.672 (39.238 / 49.735) 1.8×10−3 0.76
pHF [%] 47.844 (44.405 / 51.523) 53.328 (50.265 / 60.762) 1.8×10−3 0.76
LF/HF [a.u.] 1.090 (0.941 / 1.252) 0.875 (0.646 / 0.989) 1.8×10−3 0.76
2 hours before POAF
SDSD [ms] 0.014 (0.010 / 0.026) 0.036 (0.018 / 0.058) 3.6×10−3 0.75
RMSSD [ms] 0.014 (0.010 / 0.026) 0.036 (0.018 / 0.058) 3.6×10−3 0.75
HF [ms2] 0.469 (0.382 / 0.611) 1.050 (0.528 / 1.540) 4.5×10−3 0.74
pLF [%] 53.194 (47.798 / 55.715) 46.132 (41.862 / 49.871) 5.6×10−3 0.74
pHF [%] 46.806 (44.285 / 52.202) 53.868 (50.129 / 58.138) 5.6×10−3 0.74
LF/HF [a.u.] 1.136 (0.916 / 1.258) 0.856 (0.721 / 0.995) 5.6×10−3 0.74
42 hours before POAF
NN50 [a.u.] 7.000 (1.000 / 31.000) 29.000 (11.500 / 115.250) 7.4×10−3 0.74
pNN50 [a.u.] 0.001 (0.000 / 0.006) 0.006 (0.002 / 0.023) 9.5×10−3 0.73
48 hours before POAF
VLF [ms2] 3.894 (3.483 / 4.427) 3.445 (3.152 / 3.638) 4.7×10−3 0.76
Table 6.6: Classification results obtained when predicting postoperative at the several
tested timestamps.
Hours before POAF
48h 42h 36h 30h 24h 18h 12h 6h 4h 2h 1h
Sensitivity 0.74 0.77 0.74 0.74 0.81 0.82 0.92 0.83 0.87 0.88 0.89
Specificity 0.70 0.79 0.79 0.74 0.72 0.79 0.76 0.76 0.75 0.79 0.78
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Poff amp < -0.06   Poff amp >= -0.06
  Qamp < -0.01   Qamp >= -0.01
Pamp Rnorm < 0.02 Pamp Rnorm >= 0.02
PQoff RRnorm < 0.02 PQoff RRnorm >= 0.02
CTM(Pmagn.) < 0.956 CTM(Pmagn.) >= 0.956
CTM(Pdur.) < 0.999 CTM(Pdur.) >= 0.999
CTM(Prms norm.) < 0.725 CTM(Prms norm.) >= 0.725
Figure 6.4: Decision tree used to predict postoperative atrial fibrillation. This model used metrics from mean feature calculations and
non-linear variability (central tendency measurement; CTM) variability.
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6.4 Discussion
POAF is the most common complication of cardiac surgery. It can be life-threatening,
increases hospital length of stay, and entails additional treatment costs. Prophylactic
treatment has been shown to be effective, and may be beneficial if the patients at risk of
POAF could be identified early enough.
In the present study we aimed to predict the occurrence of POAF up to 48 hours before
its onset by analysing ECG signals from a real world clinical dataset, without supervision.
Thus, this study has aimed to predict POAF in a scenario similar to that found in the
clinical practice.
We found several P-wave and HRV metrics to be predictive of POAF, even far away
from the arrhythmia onset. P-wave variability was again the best predictor, as it provided
the highest number of significant features both close and far from the arrhythmia. Overall,
we found patients who developed POAF to have greater and increasing P-wave variability,
while controls had less and decreasing variability (Figure 6.6). The analysis was con-
ducted without supervision for the great majority of records, except for 4.7%, where the
P-wave delineation processes needed to be manually adjusted. POAF was predicted by
combining metrics derived from mean feature calculations and non-linear variability.
48h 42h 36h 30h 24h 18h 12h 6h 4h 2h 1h
Hours before POAF
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Figure 6.5: Sensitivity and specificity obtained when trying to predict postoperative atrial
fibrillation. The ability to predict POAF increased as the arrhythmia got closer.
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Patient 30 hours before POAF
Control subject
Figure 6.6: Example of representative electrocardiogram signals corresponding to a pa-
tient 30 hours before the onset of postoperative atrial fibrillation (POAF; top) and a
control (bottom). Patients who develop POAF are characterized with higher variability in
P-wave morphology, as depicted.
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6.4.1 Prediction of postoperative atrial fibrillation
The ability to predict POAF increased as the arrhythmia got closer (Figure 6.5), reflecting
the increasing prominence of atrial alterations that predispose to and trigger the arrhyth-
mia. Our model was able to predict POAF 48 hours before its onset with good sensitivity
(0.74) and specificity (0.70). Even though our results were not validated in an indepen-
dent dataset, performance was assessed using 10-fold cross validation. This allowed to
minimise overfitting and to get insight on how the model performed in an independent
dataset.
Our prediction results are comparable to those from other studies (with accuracies
ranging from 0.70 to 1.00), even though slightly worst (Table 3.3). However, it must
be noted that the present study has aimed to predict POAF in a much more complex
scenario: 1) we have considered a much longer time before onset of AF (48 hours), while
most studies have only studied times close to the arrhythmia (2 hours, mostly); and 2) our
method has rejected unreliable P-waves without supervision, while most studies excluded
noisy P-waves by hand.
It is interesting to note that the decision tree used to predict POAF (Figure 6.4) used
metrics from mean calculations and non-linear variability, while the decision trees used
to predict PAF used only variability metrics (Figures 5.10 and 5.11). However, it should be
remarked that the prediction of PAF and POAF should probably be performed separately
(i.e., using different models), because they arise from two different contexts. For example,
surgical patients are submitted to several intra- and postoperative factors (Figure 2.4) that
dispose to POAF, which are not present in daily life. In addition, cardiac surgery causes
a reduction in the activity of the autonomic nervous system, that is also not present in
daily life [143].
6.4.2 P-wave variability in the postoperative setting
P-wave time- and morphological variability was found to be the best predictor of POAF,
by providing the greatest number of significant metrics across all the tested timestamps.
This is in line with our previous study (Chapter 5), where linear and non-linear variability
were also found to be the best predictors of PAF.
Generally, patients who had POAF exhibited higher and increasing variability in sev-
eral time and morphological features of the P-wave, throughout the studied 48 hours. It
is also interesting that controls showed decreasing variability for most of the significant
variability regression metrics. The changes which occur during recovery from surgery
may explain these results. All surgical patients are subjected to several intra- and postop-
erative factors which dispose to POAF (Figure 2.4). However, controls and POAF patients
seem to respond differently to such stimulae: while controls recover from it, showing
decreasing variability, patients who develop POAF seem not to, presenting the higher and
increasing variability which eventually leads to the arrhythmia.
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Finally, it should be remarked that, unexpectedly, some metrics indicated decreased
or decreasing variability in POAF patients, while the control group showed the reverse
effect. Further studies are needed to understand if these results were false positives, or
reflect a physiological change. Nonetheless, all the results which were significant when
correcting for multiple corrections showed the expected effect of increased and increasing
variability in POAF patients.
6.4.3 Heart rate variability
The HRV analysis revealed mostly a high number of autonomic changes close to the
arrhythmia start. Indeed, the 2 hours preceding AF have been identified as a critical time
where short-term autonomic changes influencing the trigger of this arrhythmia are likely
to occur [139]. There were also relevant alterations in HRV markers a fairly long time
before the arrhythmia (at least 42 hours). All these metrics showed good predictive value,
as measured using the AUC.
Our results are in line with previous studies showing POAF patients to have: 1)
increased SDRR, RMSSD and pNN50 in either thoracic [139] or coronary artery bypass
grafting (CABG) [144] surgery; and 2) increased HF and decreased LF/HF ratio in both
surgery types [88, 139, 145]. In opposition to our findings, there are also associations of
increased LF [139] and LF/HF ratio [144] in patients who developed POAF. However, it
is important to note that these differences may arise due to other factors that may differ
between studies, such as the surgery type, disease states, medications, circadian rhythms
and respiratory rate [139]. It is also interesting to note how these results of increased heart
rate complexity in patients who developed POAF are in opposition to the findings in PAF,
where complexity is often decreased, which may suggest different triggering mechanisms.
Finally, even though POAF patients were significantly older than controls, our results of
increased HRV in that group are not likely explained by age, given that HRV decreases
with ageing [146].
6.4.4 Data inclusion
One important characteristic of a predicting tool aimed for use in a real world clinical
setting is its ability to work without supervision. In the present work we aimed to predict
POAF in an unsupervised fashion. There are at least two factors that affect the accu-
racy of AF prediction: noise, which leads to a high number of false alarms, and faulty
delineations, which cause erroneous feature measurements.
Noise was addressed by combining an ECG signal quality index and the P-wave qual-
ity index tool, which worked well for the great majority of recordings. However, from
the records that were excluded from the analysis, 10.3% were unnecessarily removed
because the P-wave template created during the P-wave quality analysis was corrupted by
noise, which affected the quality assessment, and led to discarding those records. Indeed,
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the impact of excessive noise on the P-wave template creation has been identified as a
limitation of that tool (Subsection 4.4.1).
Furthermore, 4.7% of the records included in the analysis needed their P-wave delin-
eations to be manually optimised. Otherwise, P-wave features and metrics would have
been wrongly estimated, affecting the prediction of AF. Future improvements in P-wave
delineation would help to mitigate this issue. For instance, comparison of the P-wave
signal (i.e. between the delineated onset and offset) with a Gaussian function or with a
P-wave template could help to identify abnormal delineations. Moreover, identification
of implausible P-wave feature variations could also be helpful. Currently, one P-wave
delineator compares each delineated P-wave with a reference P-wave, and excludes them
if they present a large difference (>25%) in a set of extracted features [147]. Applying
such decision rules to detect faulty delineations, could result in modifications in the
delineation parameters, improving the delineation.
6.4.5 Limitations and future work
Even though the proposed predictive model has achieved good classification performance,
it was still not reliable enough to be implemented and used. Classification ability may
be further improved with the combination of POAF risk factors and preoperative ECG
features, which have shown good predictive value on their own (Table 3.2). Furthermore,
the use of more complex classification models might improve the ability to predict AF.
In addition, as discussed, several other aspects still need to be considered so that the
prediction of POAF might be performed in the clinical practice:
1. Improvement in the signal quality assessment, so that noise does not affect the
subsequent stages of the algorithm, such as P-wave template creation;
2. Optimization of P-wave delineation for all possible variations in P-wave morphology.
An optimal algorithm would detect failures in delineation and automatically adjust
its parameters.
3. Study of a broader control group, including all heart rhythms other than AF and
atrial flutter.
Finally, this study presents some limitations that merit consideration. Firstly, the
sample of POAF patients was small (19 subjects). Larger prospective studies are therefore
needed to further validate our findings and our predictive model. Secondly, the two
groups were not matched with regard to patient age and surgery type. Finally, the ECG
recordings from the two groups were also not matched with regard to the time since
surgery. Nonetheless, our study represents a more real scenario where controls started
being monitored at a random time after the surgery.
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6.5 Final Remarks
This chapter has presented a study on the prediction of POAF. The aim of this study was
to predict POAF in a clinically relevant scenario: with up to 48 hours of antecedence and
without supervision. Thus, this study aimed to predict POAF in a scenario similar to
that found in the clinical practice. Prediction of POAF was studied using the methods
presented in Chapter 5, and at the following timestamps prior to the arrhythmia onset:
1h, 2h, 4h, 6h, 12h, 18h, 24h, 30h, 36h, 42h, and 48h. Several P-wave and HRV metrics
were predictive of POAF, even far away from the arrhythmia onset. P-wave variability
was again the best predictor, regardless of the time until the arrhythmia onset. Prediction
of POAF was performed, mostly without supervision, up to 48 hours before its onset with
with good sensitivity (0.74) and specificity (0.70).
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Conclusion
This chapter concludes the thesis by presenting an overview of its achievements, and
recommended directions for future research.
7.1 Summary of thesis achievements
The aim of this thesis was to provide a proof of concept that postoperative atrial fibrilla-
tion (POAF) can be predicted using the electrocardiogram (ECG), with sufficient warning
time for prophylactic treatments to be used. Chapters 3 to 6 presented investigations to
address these aims. The achievements of the thesis are summarized as follows:
Chapter 3: State of the art on the prediction of postoperative atrial
fibrillation
Chapter 3 presented a review of techniques previously proposed to predict POAF. These
methods were divided into preoperative methods, which aim to identify patients at risk
of developing POAF, and postoperative methods, designed to predict the imminent onset
of atrial fibrillation (AF) using continuous monitoring.
The review indicated that preoperative risk stratification models are of clinical inter-
est, but of limited applicability, given that they are not sufficiently reliable (the highest
accuracy was 0.83). Moreover, novel studies were identified that perform beat-to-beat
analyses of the ECG during continuous monitoring with promising results (accuracy
ranged from 0.70 to 1.00). These studies found that variability in the P-wave (the wave
that reflects atrial depolarization) time- and morphological features is predictive of parox-
ysmal AF.
The findings of the literature review were used to identify key areas for future re-
search, which were addressed during this thesis. The identified directions for future
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research were: 1) to develop techniques that ensure that the measurements extracted
from signals are reliable; 2) to perform a comprehensive comparison of predictive meth-
ods, and to test whether combining methods improves the prediction of AF; and 3) to
assess the performance of these algorithms in a scenario that is clinically relevant for the
prediction of POAF.
Chapter 4: Assessment of P-wave quality
Chapter 4 presented and assessed the performance and utility of a novel tool that assesses
P-wave quality. The aim of developing this tool was to ensure that only high quality and
reliable P-waves were used in the AF prediction analyses.
The tool consisted of a two-stage algorithm which used P-wave template matching
to assess quality. Its performance and utility was assessed using the AFPDB, a database
of wearable ECG signals acquired from both healthy subjects and patients susceptible to
paroxysmal AF. The algorithm’s quality assessments of 97,989 P-waves were compared
to manual annotations. The algorithm identified high quality P-waves with high sensi-
tivity (0.93) and good specificity (0.82). The tool’s clinical utility was assessed using: 1)
mean absolute error comparisons of several well-known P-wave measurements (such as
duration and amplitude) with and without the tool; and 2) evaluation of the performance
of AF prediction by using metrics extracted from the P-waves with and without the tool.
The tool improved the precision of feature measurements, and improved the prediction
of AF, especially when using methods that analyse P-wave variability.
This tool will be especially useful with the future implementation of techniques that
predict AF during long term monitoring using wearable sensors. This tool was used in
the AF prediction analyses in Chapters 5 and 6.
Chapter 5: Prediction of paroxysmal atrial fibrillation
Chapter 5 presented a study on the prediction of paroxysmal AF, following the approach
of the 2001 Computers in Cardiology challenge. The aim of this challenge was to identify
subjects at risk of developing AF, and to predict the imminent onset of AF in patients
known to be at risk. In this study, a selection of previously proposed methods were
compared, and we investigated whether combining methods improved prediction of AF.
This study used ECG recordings from 31 healthy subjects, 14 AF patients far away from
the arrhythmia onset, and 15 AF patients just before arrhythmia onset.
Prediction of AF was performed as follows. Firstly, P-waves were delineated, and their
quality was assessed automatically using the tool presented in Chapter 4. Secondly, a
set of features was extracted from each high quality P-wave. Then, each time-series of
feature measurements was summarised as a single metric using a selection of methods.
Extracted metrics ranged from simple statistical indices such as the mean and standard
deviation, to more complex measurements of variability, including heart rate variability
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(HRV). Finally, the predictive ability of those metrics was tested individually and in
combination.
Variability in P-wave time- and morphological features was found to be the best pre-
dictor of AF. Indeed, similarly to previous studies, we found that P-wave variability is
greater in patients at risk of AF, and increases as the arrhythmia gets closer. Moreover, the
autonomic nervous system was found to be altered in patients at risk of AF, as indicated
by the HRV analysis. Finally, the combination of several metrics improved the predic-
tion of AF. We could identify patients at risk of AF and to predict the imminent onset
with good sensitivity (0.82) and high specificity (0.93). Performance might be further
improved with the use of more complex classification models.
The low sampling frequency used in this study (128Hz) might have hindered accurate
P-wave characterization, and consequently might have attenuated subtle and predictive
P-wave modifications. Given that ECG devices used in the clinical setting commonly
have low sampling frequencies, this study was useful for identifying metrics capable of
predicting AF in such a context.
Further prospective studies with a larger sample size, considering wider time intervals
before the onset of AF, including other heart rhythms and types of arrhythmias, and using
commonly found sampling frequencies will be useful for the validation of these predictive
techniques.
Chapter 6: Prediction of postoperative atrial fibrillation
Chapter 6 presented a study on the prediction of POAF using the MIMIC-III database.
This study investigated the ability of the previously proposed methods to predict POAF
up to 48 hours before its start, in a real world clinical scenario. This study was the first
testing the ability of the variability methods to predict POAF. Furthermore, this study
was the first studying the prediction of AF so long before from the arrhythmia onset (48
hours). Prediction of POAF was performed as in Chapter 5. This study included records
from 48 controls and 19 patients who developed POAF.
P-wave variability was again the best predictor of AF, regardless of the time until
the arrhythmia onset. Patients who developed POAF had greater and increasing P-wave
variability, whilst controls had less and decreasing variability. This might indicate that
while controls recover (decreasing variability) from the several intra- and postoperative
factors that lead to POAF, the condition of patients who develop POAF seems to deterio-
rate further (increasing variability), leading to the arrhythmia. The autonomic nervous
system was also found to have a role in POAF, both close (< 2 hours) and far (> 42 hours)
from the arrhythmia, as indicated by the HRV analysis.
The combination of several metrics allowed POAF to be predicted 48 hours before its
onset with good sensitivity (0.74) and specificity (0.70). Performance improved as the
arrhythmia got closer. Even though these results were slightly worse than those from
previous studies, this study aimed to predict POAF in a more complex scenario: 1) 48
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hours away from the arrhythmia, whereas previous studies have mostly investigated the
2 hours before AF; and 2) mostly without supervision. Finally, automated P-wave quality
assessment and delineation was good for the great majority of records, but not for a small
minority.
Further studies with a larger sample size, and with the progressive inclusion of more
heart rhythms are warranted. Further improvements in automated signal quality assess-
ment and P-wave delineation will also be important in order to maximise the performance
of AF prediction techniques, especially when used in the clinical setting.
7.2 Future work
Even though this work has addressed several aspects that are important for the clini-
cal integration of AF prediction techniques, the performance of these methods is still
suboptimal. Several aspects that need further improvement are now discussed.
7.2.1 Reliability of P-wave measurements
The prediction of AF is highly reliant on the extraction of measurements from P-waves.
However, P-waves are of low-amplitude, making them difficult to delineate, and are
highly susceptible to noise. Measurements derived from a wrongly delineated or noise-
corrupted P-wave are often erroneous, reducing the accuracy of the prediction methods.
Hence, making sure that only high quality and well delineated P-waves are used in the
analysis is of utmost importance. Even though we have addressed this issue during this
thesis, there are still ways in which this can be improved further.
P-wave delineation
During this thesis, we tested two different P-wave delineators (see Appendix A), and chose
to use one based on the phasor transform because it performed better in ECG recordings
from subjects susceptible to AF. However, during our analyses (Chapters 5 and 6) the
parameters of the delineator had to be adjusted so that the delineation of some records
was acceptable and reliable. Even though this was performed only to a small minority
of records, this manual step is not feasible in the clinical setting, especially because the
number of patients in hospital and severities of illnesses are increasing, while staffing
levels are decreasing [119].
Hence, further work should focus on the improvement of P-wave delineation. One
way in which this can be done is with the addition of verification stages. For instance,
comparison of the P-wave signal (i.e, between the delineated onset and offset) with a Gaus-
sian function or with a P-wave template could help to identify substantially abnormal
delineations (e.g., P-wave onset in the middle of a fragmented P-wave, or P-wave offset in
the Q-wave). Furthermore, identification of implausible P-wave feature variations could
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also be helpful. To this end, one recent P-wave delineator compares each delineated P-
wave with a reference P-wave, and excludes them if they present a large difference (>25%)
in a set of extracted features [147]. In addition, the signal quality index (SQI) algorithm
used in Chapter 6 also compares the RR intervals with a series of thresholds to determine
whether their values are physiologically plausible [114]. Applying such decision rules to
detect faulty P-wave delineations, could result in changes in the delineation parameters
(e.g., in the P-wave peak search window), improving delineations.
P-wave quality assessment
Even though the P-wave quality assessment (PQI) tool presented in this thesis identified
low quality P-waves with good performance, its performance on the MIMIC-III database
was not perfect. Indeed, during that analysis, out of the 77 hour-long records that were
removed due to excessive noise, 10.3% were unnecessarily excluded because P-wave tem-
plates were affected by noise, affecting the quality assessment. Even though this happened
to a low percentage of records, clinically, this would delay or prevent the prediction of
AF (at least by one hour, the record’s duration).
Hence, further studies should improve the PQI tool so that it works well indepen-
dently of the type of artefacts present in the records. A way in which this can be ad-
dressed is with the addition of a P-wave template verification stage. For instance, a
template-verification stage where the obtained P-wave template could be compared with
a Gaussian function, would safeguard the existence of a noise-corrupted P-wave template.
Furthermore, during the creation of template P-waves, it is assumed that the ECG
recording has a single P-wave morphology, thus ignoring the possibility of a secondary
P-wave morphology. Indeed, a recent study has found an increased number of P-waves
matching a distinct secondary morphology to be significantly associated with paroxysmal
AF, possibly indicating different conduction routes on the atrial myocardium [120]. If
those secondary morphologies significantly differ from the main morphology of the cre-
ated template, they will probably be classified as low quality and will consequently be
discarded from the analysis. Thus, future improvements in P-wave quality assessment
could include the possibility of an additional P-wave morphology with, for example, the
creation of two different P-wave templates that could then be used to extract P-wave
features and assess its quality.
7.2.2 Prediction of atrial fibrillation
Even though the methods used to predict AF obtained good and promising results, their
performance was still insufficient for implementation in the clinical setting. There exist
at least four ways in which prediction of POAF can be improved in the future:
1. Inclusion of risk factors (such as age, gender, medications) and preoperative ECG
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features to improve performance. The combination of preoperative risk stratifica-
tion and postoperative prediction models has not been reported. Given that these
techniques achieve good performance separately, their combination could be of in-
terest. In addition, variability analyses of preoperative ECG signals have never been
performed and might also be of interest.
2. Development of other methods to measure the variability of the extracted P-wave
features. In this regard, methods used to study HRV might be of interest.
3. Development of more complex classification models that can improve the perfor-
mance to predict AF (e.g., support vector machine classifiers). However, care should
be taken in order to avoid overfitting.
4. Inclusion of other physiological monitoring techniques, such as the photoplethys-
mogram (PPG). The PPG is an optical measurement technique that detects blood
volume changes in the microvascular bed of tissue, providing information on the
heart and the vascular and autonomic nervous systems. The PPG is an useful car-
diac arrhythmia detector as it is very sensitive to any irregularity of the pulse. This
is particularly apparent in phenomena such as atrial or ventricular premature beats.
Recent studies have shown the PPG signal to be a reliable tool to detect and diagnose
AF rhythm [148–150].
In addition, future studies should keep addressing the prediction of POAF under
scenarios that are clinically relevant. Future research should then:
1. Study the prediction of AF at a time where it is still possible to prevent the arrhyth-
mia.
2. Include diverse heart rhythms. Even though atrial fibrillation is the most com-
mon heart rhythm disorder in the postoperative period, other heart rhythms and
arrhythmias can occur, such as tachyarrhythmias and bradyarrhythmias [110]. It is
important to include these rhythms in future studies to ensure that the prediction
of POAF in the clinical setting is reliable. To date, studies have only included ECG
recordings during sinus rhythm.
3. Study the prediction of AF without supervision and using signals obtained from
continuous monitoring of patients.
4. Study the prediction of POAF following other surgery types. To date, most studies
have only aimed to predict POAF after cardiac surgery.
Finally, even though several studies have addressed the prediction of AF using con-
tinuous ECG monitoring, they have analysed small populations (the largest study has
included 46 patients with paroxysmal AF and 53 healthy subjects; Table 3.3). Hence, in
order to develop reliable prediction techniques, they must be tested and validated in a
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substantially larger population. Freely available databases containing physiological mea-
surements from intensive unit care (ICU) patients, such as the MIMIC-III [142] database,
will help mitigate this issue, as they usually contain data for large populations.
7.3 Application in clinical practice
Hospital patients recovering from major cardiac surgery are at high risk of POAF, which
can be life-threatening. By predicting the POAF early enough, the development of the
arrhythmia could be potentially prevented using prophylactic treatments, thus reducing
risks and hospital costs. The prophylactic effect depends on the pharmacokinetics of the
drugs used (e.g., administered dose, rate of absorption, and rate of elimination). The
pharmacokinetic parameter we are most interested is the time of onset of antiarrhythmic
effect, which varies from drug to drug. In this application, it would be optimal if the
prophylactic treatments peaked their effect as fast as possible, ideally the furthest from
POAF onset.
There are two prophylactic drugs recommended for POAF prevention: beta-blockers
and amiodarone (Section 2.3.4). The anti-arrhythmic effect of beta-blockers peaks imme-
diately when administered intravenously (IV), and after 1 to 1.5 hours when administered
orally [57]. In contrast, the anti-arrhythmic effect of amiodarone peaks between 1 minute
and 1.5 hours after IV administration [62]. When administered orally, the drug concen-
tration peaks after 3 to 7 hours [63, 64], but the anti-arrhythmic effects only start after 2
to 3 days [62, 65].
The hypothesis of this thesis is that ECG signals can be analysed to predict the onset
of POAF with sufficient warning time to allow prophylactic treatment to be administered.
In this thesis, a tool was developed to predict POAF, showing good sensitivity (0.74) and
specificity (0.70) 48 hours before its onset (Chapter 6). Hence, by applying this tool, one
would have the next 47 hours to prevent the onset of AF using prophylactic treatments.
Despite the existence of several therapeutic plans (e.g., administration of amiodarone
400mg firstly IV and four days later orally), the aforementioned numbers suggest that
the time between predicting POAF and its onset is sufficiently large for the prophylactic
treatments to take anti-arrhythmic effects and consequently enable the prevention of
POAF.
Nonetheless, further studies are required in order to determine which prophylactic
drug and therapeutic plan is the best suited for this particular scenario, where the drugs
need to be necessarily administered postoperatively, and during the time between pre-
dicting POAF and its onset. In addition, the efficiency of those treatments might also be
monitored using the ECG. For instance, if it was possible to detect that a given prophylac-
tic treatment was not efficiently preventing POAF, the drug and/or the therapeutic plan
could be altered and tailored.
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Appendix A: Comparison of P-wave
delineators
This appendix presents a comparison of two P-wave delineators: one using the phasor
transform (PT), and other based on the wavelet transform. The aim of this study was to
select the delineator which is best suited to be used in atrial fibrillation (AF) prediction
analyses. The ability of the algorithms to delineate P-waves was compared using: 1)
comparisons of P-wave delineations with manual annotations; and 2) visual inspection
of P-wave delineations on electrocardiogram (ECG) recordings from healthy subjects and
patients prone to AF.
A.1 Introduction
The P-wave from the ECG represents the electrical activity of the atria and provides in-
formation about atrial conduction. Recent studies have found that patients who develop
AF have greater variability in P-wave morphology and time-intervals [25–27, 105, 107,
108]. Hence, the prediction of AF is highly reliant on the accurate delineation of P-waves.
Measurements derived from wrongly delineated P-waves are often erroneous, which com-
promises the accuracy of the prediction methods. In addition, P-wave delineation must be
performed automatically, so that AF might be predicted during unsupervised continuous
monitoring.
Many different methods for delineating P-waves have been introduced. Their strate-
gies range from the use of mathematical transforms, such as the PT [104] or the wavelet
transform [103], to the use Gaussian models [147]. In this study we present a comparison
of two P-wave delineators, one using the PT and other using the Dyadic wavelet transform
(wavedet algorithm), with the aim of selecting the delineator which will be used in the
AF prediction analyses of this thesis.
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A.2 Methods
The ability of the PT and wavedet algorithms to delineate P-waves was compared using:
1) comparisons of the P-wave delineations provided by the algorithm with manual an-
notations from the QT database (QTDB) [122]; and 2) visual inspection of the P-wave
delineations provided by the algorithms in the AF prediction database (AFPDB) [90].
A.2.1 Comparisons with manual annotations
The QTDB was used to compare the performance of the two delineators from real ECGs.
The database was developed for wave limit validation purposes, and contains annotations
by an expert cardiologist for at least 30 beats per recording, including P-wave onset, peak
and offset [122].
The delineators were applied to the bandpass-filtered (between 0.5 and 40Hz) ECG
signals and their accuracy to delineate P-wave onset, peak and offset was assessed using
the location error (LE). LE was was computed as the subtraction of the automatic delin-
eations (obtained with the algorithms) from the manual annotations (Figure A.1). Given
that both delineators work on a single-channel basis, it has to remarked that the manual
annotations on the QTDB were performed having the two available leads in sight. To
minimise this discrepancy, the two channels were delineated individually and the LE was
computed for each channel, but only the smaller of the two LEs was selected. In addition,
the error in P-wave duration was also calculated.
Finally, the performance of the delineators was compared using the limits of agree-
ment (LoA), a technique widely used to compare two measuring methods [151, 152]. The
following statistics were computed:
1. Bias (corresponding to the mean of all LEs).
2. Standard deviation (SD) of LEs. Allows to compute the expected range of 95% of er-
rors around the systematic bias, given by ±1.96SD ("2SD"). The standard deviation
of errors is given by SD =
√
total variance, where the total variance is the sum of the
within-subjects and between subjects variance. Hence, the standard deviation can
be computed as:
SD =
√
within-subjects variance + between-subjects variance (A.1)
The two variance components can be estimated using one-way analysis of variance:
within-subjects variance =MSresidual , and (A.2)
between-subjects variance =
MSsubject −MSresidual
(
∑
mi )
2−∑m2i
(n−1)∑mi
, (A.3)
where MSresidual is the mean square error, and MSsubject is the difference between
the mean squares for ECG records, n is the number of records, andmi is the number
of delineations for the ith record.
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Figure A.1: Representative example of the calculation of the location error (LE), obtained
by subtracting the delineation obtained using the automatic delineator (red) from the
manual annotation (green).
A.2.2 Visual inspection of P-wave delineations
The AFPDB database contains ECG recordings from healthy subjects and patients who
subsequently developed paroxysmal AF. Given that this analysis aimed to choose the best
delineator to be used in AF prediction, it was important to inspect how the two delin-
eators performed in that context. From the 61 records containing P-waves, we randomly
selected 36, and visually inspected the delineations from both delineators. The number
of records in which the overall P-wave delineations were bad was annotated. A record
was considered to have bad P-wave delineations if any of the delineated fiducial points
(onset, peak or offset) affected substantially the extraction of features (e.g., duration) for
a large percentage of beats.
A.3 Results
Table A.1 shows the bias and SD of the P-wave delineation LEs for the PT and wavedet
algorithms. The wavedet algorithm presented lower LE bias in all P-wave fiducial points,
and lower SD in P-wave onset LE and duration.
Regarding the visual inspection of P-wave delineations in the AFPDB, the wavedet
algorithm presented good P-wave delineations in 41.7% of records, while the delineations
of the PT algorithm were good in 77.8%.
A.4 Discussion
During this analysis we aimed to select the delineator best suited to be applied in AF
prediction analyses. From the LE analysis, we found that, even though the wavedet
algorithm outperformed the PT algorithm, both approaches gave satisfactory results.
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Table A.1: Comparison of the delineation performance of the phasor transform and
wavedet algorithms, measured with the location error.
Phasor transform algorithm
Statistics P-wave onset P-wave peak P-wave offset P-wave duration
Bias (ms) -4.23 -4.90 -15.75 -2.87
SD (ms) 28.12 21.50 22.16 7.47
Wavedet algorithm
Statistics P-wave onset P-wave peak P-wave offset P-wave duration
Bias (ms) 1.40 1.42 6.14 1.19
SD (ms) 26.84 25.17 23.68 7.12
However, the performance of the PT algorithm in the AFPDB was much better than that
of the wavedet algorithm. Taken together, these results show that the PT algorithm is
most suited to be applied in AF prediction analyses.
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